{"display": {"sizeBy": "size", "colorBy": "color", "hideMenu": true, "showLegend": false, "gravity": 0.7, "width": 600, "height": 600, "scaleLinkOpacity": true, "scaleLinkWidth": true, "scales": {"nodeSize": {"min": 0.7, "max": 2}}}, "networks": {"webweb": {"layers": [{"edgeList": [["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Christopher H. Arehart"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Meng Lin"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Raine A. Gibson"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Heather D. Anderson"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Christina L. Aquilante"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Kelsey Arbogast"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Christopher H. Arehart"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Ian M. Brooks"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Tonya M. Brunetti"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Judith Brutus-Lestin"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Elizabeth E. Burke"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Emily M. Casteel"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Joanne B. Cole"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Curtis R. Coughlin"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Kristy Crooks"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Jacob Crawford"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Erin Culver"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Michelle N. Edelmann"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Matthew J. Fisher"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Alan W. Franklin"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Teresa C. Frye"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Hunter George"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Christopher R. Gignoux"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Elizabeth K. Gilliland"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Casey S. Greene"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Brooke Hawkes"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Emily Hearst"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Audrey E. Hendricks"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Randi K. Johnson"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Colleen G. Julian"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Dave Kao"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Iain Konigsberg"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Lisa Ku"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Elizabeth L. Kudron"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Rashawnda Lacy"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Ethan M. Lange"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Yee Ming Lee"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Joe A. Lesny"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Meng Lin"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Jan T. Lowery"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Luciana B. Vargas"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Betzaida L. Maldonado"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Darcy Marceau"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "James L. Martin"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Brianna L. Gates"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "David Mayer"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Nicole L. McDaniel"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Andrew Monte"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Ethan Moore"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Ann Nadrash"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Jack Pattee"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Nikita Pozdeyev"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Alaa Radwan"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Nick Rafaels"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Sridharan Raghavan"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Neda Rasouli"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Elise L. Shalowitz"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Hoda Sherif"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Johnathan A. Shortt"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Adrian M. Stewart"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Kristen J. Sutton"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Carolyn T. Swartz"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Anna Tanaka"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Matthew R. G. Taylor"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Candace Teague"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Emily B. Todd"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Katy E. Trinkley"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Laura K. Wiley"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Sridharan Raghavan"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Christopher R. Gignoux"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Maggie Stanislawski"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Andrew D. Grotzinger"], ["Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "Luke M. Evans"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Ashley Scadden"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Aastha Kakar"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Elizabeth M Litkowski"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Mariah C Meyer"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Nicole D Armstrong"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Steven Buyske"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Yanwei Cai"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Iona Cheng"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Burcu F Darst"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Myriam Fornage"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Mariaelisa Graff"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Boya Guo"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Christopher A Haiman"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Heather M Highland"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Charles Kooperberg"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Lo\u00efc Le Marchand"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Kari North"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Ulrike Peters"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Stephen S Rich"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Jerome I Rotter"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Vinodh Srinivasasainagendra"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Hemant K Tiwari"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Stephanie Waldrop"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Kristin Young"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Sridharan Raghavan"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Ethan M Lange"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Leslie A Lange"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Marguerite R Irvin"], ["Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "Maggie Stanislawski"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Xinruo Zhang"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Ashley Scadden"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Amarnath Marthi"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Victoria L Buchanan"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Yishu Qu"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Kendra R Ferrier"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Brian D Chen"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Mariaelisa Graff"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Julian Avila"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Eric Boerwinkle"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Steven Buyske"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Clary B Clish"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Dan Cruz"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Myriam Fornage"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Robert E Gerzsten"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Christopher R Gignoux"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "LaShaunta Glover"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Lifang Hou"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Anne E Justice"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Charles Kooperberg"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Holly Kramer"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Leslie Lange"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Ruth J F Loos"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Tara Matise"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Josyf C Mychaleckyj"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Opeyemi A Olabisi"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Ulrike Peters"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Laura M Raffield"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Alex P Reiner"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Stephen S Rich"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Jerome I Rotter"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Kent D Taylor"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Bing Yu"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Yinan Zheng"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Kari E North"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Amy K Mottl"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Heather M Highland"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "Maggie Stanislawski"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Aastha Kakar"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Elizabeth M. Litkowski"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Ashley Scadden"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Mohammad Y. Anwar"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Iain R. Konigsberg"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Maggie Stanislawski"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Natalie C. DuPre"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Riten Mitra"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Richard Baumgartner"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Laura M. Raffield"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Ethan M. Lange"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Leslie A. Lange"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Kira C. Taylor"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Luciana B. Vargas"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Mariah C. Meyer"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Iain R. Konigsberg"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Aastha Kakar"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Patrick M. Carry"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Yun Li"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Alana C. Jones"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Hemant K. Tiwari"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Vinodh Srinivasasainagendra"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Nicole D. Armstrong"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Eimear E. Kenny"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Bogdan Pasaniuc"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Marguerite R. Irvin"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Michael H. Cho"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Maggie Stanislawski"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Sridharan Raghavan"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Jonathan A. Shortt"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Leslie A. Lange"], ["Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "Ethan M. Lange"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Kendra Ferrier"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Mariaelisa Graff"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Iain R. Konigsberg"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Maggie Stanislawski"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Heather M. Highland"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Laura M. Raffield"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "April P. Carson"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Eric Boerwinkle"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Jill M. Norris"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Chris R. Gignoux"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Audrey E. Hendricks"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Sridharan Raghavan"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Kari E. North"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Matthew A. Allison"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Mathew J. Budoff"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Silva Kasela"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Fran\u00e7ois Aguet"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Joshua J. Joseph"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Charles Kooperberg"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Stephen S. Rich"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Jerome I. Rotter"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Ethan M. Lange"], ["Epigenome-wide association study meta-analysis of BMI in African American Adults", "Leslie A. Lange"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Mohammad Y. Anwar"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Heather Highland"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Victoria Lynn Buchanan"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Mariaelisa Graff"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Kristin Young"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Kent D. Taylor"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Russell P. Tracy"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Peter Durda"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Yongmei Liu"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Craig W. Johnson"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Francois Aguet"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Kristin G. Ardlie"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Robert E. Gerszten"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Clary B. Clish"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Leslie A. Lange"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Jingzhong Ding"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Mark O. Goodarzi"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Yii\u2010Der Ida Chen"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Gina M. Peloso"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Xiuqing Guo"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Maggie Stanislawski"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Jerome I. Rotter"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Stephen S. Rich"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Anne E. Justice"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Ching\u2010ti Liu"], ["Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "Kari North"], ["EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies", "Jennifer Fouquier"], ["EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies", "Maggie Stanislawski"], ["EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies", "John O\u2019Connor"], ["EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies", "Ashley Scadden"], ["EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies", "Catherine Lozupone"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "Christopher H Arehart"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "John D Sterrett"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "Rosanna L Garris"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "Ruth E Quispe-Pilco"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "Christopher R Gignoux"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "Luke M Evans"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "Maggie Stanislawski"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Katherine G. Young"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Eram Haider McInnes"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert J. Massey"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Anna R. Kahkoska"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Scott J. Pilla"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sridharan Raghavan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Maggie Stanislawski"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Deirdre K. Tobias"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Andrew P. McGovern"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Adem Y. Dawed"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Angus G. Jones"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ewan R. Pearson"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "John M. Dennis"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Deirdre K. Tobias"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jordi Merino"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Abrar Ahmad"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Catherine Aiken"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jamie L. Benham"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Dhanasekaran Bodhini"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Amy L. Clark"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kevin Colclough"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rosa Corcoy"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sara J. Cromer"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Daisy Duan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jamie L. Felton"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ellen C. Francis"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Pieter Gillard"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "V\u00e9ronique Gingras"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Romy Gaillard"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Eram Haider"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Alice Hughes"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jennifer M. Ikle"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Laura M. Jacobsen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jarno L. T. Kettunen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Raymond J. Kreienkamp"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Lee-Ling Lim"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jonna M. E. M\u00e4nnist\u00f6"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert Massey"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Niamh-Maire Mclennan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rachel G. Miller"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mario Luca Morieri"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jasper Most"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rochelle N. Naylor"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Bige Ozkan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kashyap Amratlal Patel"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Scott J. Pilla"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Katsiaryna Prystupa"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sridaran Raghaven"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mary R. Rooney"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Martin Sch\u00f6n"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Zhila Semnani-Azad"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Magdalena Sevilla-Gonzalez"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Pernille Svalastoga"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Wubet Worku Takele"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Claudia Ha-ting Tam"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Anne Cathrine B. Thuesen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mustafa Tosur"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Amelia S. Wallace"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Caroline C. Wang"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jessie J. Wong"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jennifer M. Yamamoto"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Katherine Young"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Chlo\u00e9 Amouyal"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mette K. Andersen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Maxine P. Bonham"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mingling Chen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Feifei Cheng"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Tinashe Chikowore"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sian C. Chivers"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Christoffer Clemmensen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Dana Dabelea"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Adem Y. Dawed"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Aaron J. Deutsch"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Laura T. Dickens"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Linda A. DiMeglio"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Monika Dudenh\u00f6ffer-Pfeifer"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Carmella Evans-Molina"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mar\u00eda Merc\u00e8 Fern\u00e1ndez-Balsells"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Hugo Fitipaldi"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Stephanie L. Fitzpatrick"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Stephen E. Gitelman"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mark O. Goodarzi"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jessica A. Grieger"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Marta Guasch-Ferr\u00e9"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Nahal Habibi"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Torben Hansen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Chuiguo Huang"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Arianna Harris-Kawano"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Heba M. Ismail"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Benjamin Hoag"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Randi K. Johnson"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Angus G. Jones"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert W. Koivula"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Aaron Leong"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Gloria K. W. Leung"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ingrid M. Libman"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kai Liu"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "S. Alice Long"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "William L. Lowe"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert W. Morton"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ayesha A. Motala"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Suna Onengut-Gumuscu"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "James S. Pankow"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Maleesa Pathirana"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sofia Pazmino"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Dianna Perez"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "John R. Petrie"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Camille E. Powe"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Alejandra Quinteros"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rashmi Jain"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Debashree Ray"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mathias Ried-Larsen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Zeb Saeed"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Vanessa Santhakumar"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sarah Kanbour"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sudipa Sarkar"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Gabriela S. F. Monaco"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Denise M. Scholtens"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Elizabeth Selvin"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Wayne Huey-Herng Sheu"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Cate Speake"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Maggie Stanislawski"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Nele Steenackers"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Andrea K. Steck"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Norbert Stefan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Julie St\u00f8y"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rachael Taylor"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sok Cin Tye"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Gebresilasea Gendisha Ukke"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Marzhan Urazbayeva"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Bart Van der Schueren"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Camille Vatier"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "John M. Wentworth"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Wesley Hannah"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sara L. White"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Gechang Yu"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Yingchai Zhang"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Shao J. Zhou"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jacques Beltrand"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Michel Polak"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ingvild Aukrust"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Elisa de Franco"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sarah E. Flanagan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kristin A. Maloney"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Andrew McGovern"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Janne Molnes"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Mariam Nakabuye"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "P\u00e5l Rasmus Nj\u00f8lstad"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Hugo Pomares-Millan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Michele Provenzano"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "C\u00e9cile Saint-Martin"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Cuilin Zhang"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Yeyi Zhu"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Sungyoung Auh"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Russell de Souza"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Andrea J. Fawcett"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Chandra Gruber"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Eskedar Getie Mekonnen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Emily Mixter"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Diana Sherifali"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert H. Eckel"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "John J. Nolan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Louis H. Philipson"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rebecca J. Brown"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Liana K. Billings"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kristen Boyle"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Tina Costacou"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "John M. Dennis"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jose C. Florez"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Anna L. Gloyn"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Maria F. Gomez"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Peter A. Gottlieb"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Siri Atma W. Greeley"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kurt Griffin"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Andrew T. Hattersley"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Irl B. Hirsch"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Marie-France Hivert"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Korey K. Hood"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jami L. Josefson"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Soo Heon Kwak"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Lori M. Laffel"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Siew S. Lim"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ruth J. F. Loos"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ronald C. W. Ma"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Chantal Mathieu"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Nestoras Mathioudakis"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "James B. Meigs"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Shivani Misra"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Viswanathan Mohan"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rinki Murphy"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Richard Oram"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Katharine R. Owen"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Susan E. Ozanne"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Ewan R. Pearson"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Wei Perng"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Toni I. Pollin"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rodica Pop-Busui"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Richard E. Pratley"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Leanne M. Redman"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Maria J. Redondo"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Rebecca M. Reynolds"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert K. Semple"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Jennifer L. Sherr"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Emily K. Sims"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Arianne Sweeting"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Tiinamaija Tuomi"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Miriam S. Udler"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Kimberly K. Vesco"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Tina Vilsb\u00f8ll"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Robert Wagner"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Stephen S. Rich"], ["Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "Paul W. Franks"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Maryam Kavousi"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Maxime M. Bos"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Hanna J. Barnes"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Christian L. Lino Cardenas"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Doris Wong"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Haojie Lu"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Chani J. Hodonsky"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Lennart P. L. Landsmeer"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Adam W. Turner"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Minjung Kho"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Natalie R. Hasbani"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Paul S. de Vries"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Donald W. Bowden"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Sandesh Chopade"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Joris Deelen"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Ernest Diez Benavente"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Xiuqing Guo"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Edith Hofer"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Shih-Jen Hwang"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Sharon M. Lutz"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Leo-Pekka Lyytik\u00e4inen"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Lotte Slenders"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Albert V. Smith"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Maggie Stanislawski"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Jessica van Setten"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Quenna Wong"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Lisa R. Yanek"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Diane M. Becker"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Marian Beekman"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Matthew J. Budoff"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Mary F. Feitosa"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Chris Finan"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Austin T. Hilliard"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Sharon L. R. Kardia"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Jason C. Kovacic"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Brian G. Kral"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Carl D. Langefeld"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Lenore J. Launer"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Shaista Malik"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Firdaus A. A. Mohamed Hoesein"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Michal Mokry"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Reinhold Schmidt"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Jennifer A. Smith"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Kent D. Taylor"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "James G. Terry"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Jeroen van der Grond"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Joyce van Meurs"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Rozemarijn Vliegenthart"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Jianzhao Xu"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Kendra A. Young"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Nuno R. Zilh\u00e3o"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Robert Zweiker"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Themistocles L. Assimes"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Lewis C. Becker"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Daniel Bos"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "J. Jeffrey Carr"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "L. Adrienne Cupples"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Dominique P. v. de Kleijn"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Menno de Winther"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Hester M. den Ruijter"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Myriam Fornage"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Barry I. Freedman"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Vilmundur Gudnason"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Aroon D. Hingorani"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "John E. Hokanson"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "M. Arfan Ikram"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Ivana I\u0161gum"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "David R. Jacobs"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Mika K\u00e4h\u00f6nen"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Leslie A. Lange"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Terho Lehtim\u00e4ki"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Gerard Pasterkamp"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Olli T. Raitakari"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Helena Schmidt"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "P. Eline Slagboom"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Andr\u00e9 G. Uitterlinden"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Meike W. Vernooij"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Joshua C. Bis"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Nora Franceschini"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Bruce M. Psaty"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Wendy S. Post"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Jerome I. Rotter"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Johan L. M. Bj\u00f6rkegren"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Christopher J. O\u2019Donnell"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Lawrence F. Bielak"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Patricia A. Peyser"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Rajeev Malhotra"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Sander W. van der Laan"], ["Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "Clint L. Miller"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Emily B. Hill"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Iain R. Konigsberg"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Diana Ir"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Daniel N. Frank"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Purevsuren Jambal"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Elizabeth M. Litkowski"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Ethan M. Lange"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Leslie A. Lange"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Danielle M. Ostendorf"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Jared J. Scorsone"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Liza Wayland"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Kristen Bing"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Paul S. MacLean"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Edward L. Melanson"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Daniel H. Bessesen"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Victoria A. Catenacci"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Maggie Stanislawski"], ["The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "Sarah J. Borengasser"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Andrew J. Hoisington"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Christopher E. Stamper"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Katherine L. Bates"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Maggie Stanislawski"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Michael C. Flux"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Teodor T. Postolache"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Christopher A. Lowry"], ["Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "Lisa A. Brenner"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "Christopher H. Arehart"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "John D. Sterrett"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "Rosanna L. Garris"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "Ruth E. Quispe-Pilco"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "Christopher R. Gignoux"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "Luke M. Evans"], ["Poly-omic risk scores predict inflammatory bowel disease diagnosis", "Maggie Stanislawski"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Maggie Stanislawski"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Daniel N Frank"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Sarah J Borengasser"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Danielle M Ostendorf"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Diana Ir"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Purevsuren Jambal"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Kristen Bing"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Liza Wayland"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Janet C Siebert"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Daniel H Bessesen"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Paul S MacLean"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Edward L Melanson"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention.", "Victoria A Catenacci"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Maggie Stanislawski"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Christopher E Stamper"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Kelly A Stearns-Yoder"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Andrew J Hoisington"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Diana P Brostow"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Jeri E Forster"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Teodor T Postolache"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Christopher A Lowry"], ["Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "Lisa A Brenner"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Maggie Stanislawski"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Elizabeth Litkowski"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Sridharan Raghavan"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Kylie K Harrall"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Jessica Shaw"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Deborah H Glueck"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Ethan M Lange"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Dana Dabelea"], ["Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "Leslie A Lange"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Catherine C Cohen"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Wei Perng"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Katherine A Sauder"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Brandy M Ringham"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Anna Bellatorre"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Ann Scherzinger"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Maggie Stanislawski"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Leslie A Lange"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Kartik Shankar"], ["Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "Dana Dabelea"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Maggie Stanislawski"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Elizabeth Litkowski"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Ruby Fore"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Sheryl L Rifas-Shiman"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Emily Oken"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Marie-France Hivert"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Ethan M Lange"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Leslie A Lange"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Dana Dabelea"], ["Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "Sridharan Raghavan"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Maggie Stanislawski"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Leslie A Lange"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Laura M Raffield"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Neil A Zakai"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Mariah Meyer"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Kendra Ferrier"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Mindy D Szeto"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Colton Leavitt"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Jonathan A Shortt"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Timothy A Thornton"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Russell P Tracy"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Paul L Auer"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Alex P Reiner"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Ethan M Lange"], ["Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "Nels C Olson"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Janet C Siebert"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Maggie Stanislawski"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Adnin Zaman"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Danielle M Ostendorf"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Iain R Konigsberg"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Purevsuren Jambal"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Diana Ir"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Kristen Bing"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Liza Wayland"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Jared J Scorsone"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Catherine A Lozupone"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Carsten G\u00f6rg"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Daniel N Frank"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Daniel Bessesen"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Paul S MacLean"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Edward L Melanson"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Victoria A Catenacci"], ["Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "Sarah J Borengasser"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Diana P. Brostow"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Christopher E. Stamper"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Maggie Stanislawski"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Kelly A. Stearns-Yoder"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Alexandra Schneider"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Teodor T. Postolache"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Jeri E. Forster"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Andrew J. Hoisington"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Christopher A. Lowry"], ["Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "Lisa A. Brenner"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Lisa A Brenner"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Christopher E Stamper"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Andrew J Hoisington"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Kelly A Stearns-Yoder"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Maggie A Stanislawksi"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Diana P Brostow"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Claire A Hoffmire"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Jeri E Forster"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Alexandra L Schneider"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Teodor T Postolache"], ["Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "Christopher A Lowry"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Mireia Gascon"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Kylie K Harrall"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Alyssa W Beavers"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Deborah H Glueck"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Maggie Stanislawski"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Katherine Alaimo"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Angel Villalobos"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "James R Hebert"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Kelsey Dexter"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Kaigang Li"], ["Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "Jill Litt"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Joseph Walker Keach"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Maggie Stanislawski"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Anna E Bar\u00f3n"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Mary E Plomondon"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Paula Langner"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Amit Amin"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Heather M Gilmartin"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Stephen Waldo"], ["Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "Thomas M Maddox"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Archana Asundi"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Maggie Stanislawski"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Payal Mehta"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Hillary J Mull"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Marin L Schweizer"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Anna E Bar\u00f3n"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "P Michael Ho"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Kalpana Gupta"], ["Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "Westyn Branch-Elliman"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Maggie Stanislawski"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Jessica Shaw"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Elizabeth Litkowski"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Ethan M Lange"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Wei Perng"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Dana Dabelea"], ["Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "Leslie A Lange"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Hillary J Mull"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Kelly Stolzmann"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Emily Kalver"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Marlena H Shin"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Marin L Schweizer"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Archana Asundi"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Payal Mehta"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Maggie Stanislawski"], ["Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "Westyn Branch-Elliman"], ["Gut microbiota phenotypes of obesity.", "Maggie Stanislawski"], ["Gut microbiota phenotypes of obesity.", "Dana Dabelea"], ["Gut microbiota phenotypes of obesity.", "Leslie A Lange"], ["Gut microbiota phenotypes of obesity.", "Brandie D Wagner"], ["Gut microbiota phenotypes of obesity.", "Catherine A Lozupone"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Archana Asundi"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Maggie Stanislawski"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Payal Mehta"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Anna E Baron"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Hillary J Mull"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "P Michael Ho"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Peter J Zimetbaum"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Kalpana Gupta"], ["Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "Westyn Branch-Elliman"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Maggie Stanislawski"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Dana Dabelea"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Brandie D. Wagner"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Nina Iszatt"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Cecilie Dahl"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Marci K. Sontag"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Rob Knight"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Catherine A. Lozupone"], ["Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "Merete Eggesb\u00f8"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Omar Jawaid"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Maggie Stanislawski"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Rory Bricker"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Mary E Plomondon"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Gary K Grunwald"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Javier A Valle"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Ehrin J Armstrong"], ["Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "Stephen W Waldo"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Lisa A Brenner"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Andrew J Hoisington"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Kelly A Stearns-Yoder"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Christopher E Stamper"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Jared D Heinze"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Teodor T Postolache"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Daniel A Hadidi"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Claire A Hoffmire"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Maggie Stanislawski"], ["Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "Christopher A Lowry"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Susana Santos"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Iris Eekhout"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Ellis Voerman"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Romy Gaillard"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Henrique Barros"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Marie-Aline Charles"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Leda Chatzi"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "C\u00e9cile Chevrier"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "George P Chrousos"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Eva Corpeleijn"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Nathalie Costet"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Sarah Crozier"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Myriam Doyon"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Merete Eggesb\u00f8"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Maria Pia Fantini"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Sara Farchi"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Francesco Forastiere"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Luigi Gagliardi"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Vagelis Georgiu"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Keith M Godfrey"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Davide Gori"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Veit Grote"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Wojciech Hanke"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Irva Hertz-Picciotto"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Barbara Heude"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Marie-France Hivert"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Daniel Hryhorczuk"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Rae-Chi Huang"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Hazel Inskip"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Todd A Jusko"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Anne M Karvonen"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Berthold Koletzko"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Leanne K K\u00fcpers"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Hanna Lagstr\u00f6m"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Debbie A Lawlor"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Irina Lehmann"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Maria-Jose Lopez-Espinosa"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Per Magnus"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Renata Majewska"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Johanna M\u00e4kel\u00e4"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Yannis Manios"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Sheila W McDonald"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Monique Mommers"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Camilla S Morgen"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "George Moschonis"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "\u013dubica Mur\u00ednov\u00e1"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "John Newnham"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Ellen A Nohr"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Anne-Marie Nybo Andersen"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Emily Oken"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Adri\u00ebtte J J M Oostvogels"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Agnieszka Pac"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Eleni Papadopoulou"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Juha Pekkanen"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Costanza Pizzi"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Kinga Polanska"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Daniela Porta"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Lorenzo Richiardi"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Sheryl L Rifas-Shiman"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Nel Roeleveld"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Loreto Santa-Marina"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Ana C Santos"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Henriette A Smit"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Thorkild I A S\u00f8rensen"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Marie Standl"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Maggie Stanislawski"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Camilla Stoltenberg"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Elisabeth Thiering"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Carel Thijs"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Maties Torrent"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Suzanne C Tough"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Tomas Trnovec"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Marleen M H J van Gelder"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Lenie van Rossem"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Andrea von Berg"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Martine Vrijheid"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Tanja G M Vrijkotte"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Oleksandr Zvinchuk"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Stef van Buuren"], ["Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "Vincent W V Jaddoe"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Maggie Stanislawski"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Dana Dabelea"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Brandie D Wagner"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Nina Iszatt"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Cecilie Dahl"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Marci K Sontag"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Rob Knight"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Catherine A Lozupone"], ["Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "Merete Eggesb\u00f8"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Ehrin J. Armstrong"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Maggie Stanislawski"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Damianos G. Kokkinidis"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Mary E. Plomondon"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Anna E. Bar\u00f3n"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Jay Giri"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Kendrick A. Shunk"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Subhash Banerjee"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Thomas M. Maddox"], ["Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "Stephen W. Waldo"], ["Maggie Stanislawski\u2014August ECI biocommentary", "Maggie Stanislawski"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Archana Asundi"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Maggie Stanislawski"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Payal Mehta"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Anna E. Bar\u00f3n"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Howard Gold"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Hillary Mull"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "P. Michael Ho"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Kalpana Gupta"], ["Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "Westyn Branch-Elliman"], ["The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "Ateka Gunja"], ["The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "Maggie Stanislawski"], ["The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "Anna E. Bar\u00f3n"], ["The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "Thomas M. Maddox"], ["The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "Steven M. Bradley"], ["The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "Mladen I. Vidovich"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Amit N. Vora"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Maggie Stanislawski"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Gary K. Grunwald"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Mary E. Plomondon"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "John S. Rumsfeld"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Thomas M. Maddox"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Mladen I. Vidovich"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Walter Woody"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Brahmajee K. Nallamothu"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Hitinder S. Gurm"], ["Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "Sunil V. Rao"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Thomas T. Tsai"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Maggie Stanislawski"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Kendrick A. Shunk"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Ehrin J. Armstrong"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Gary K. Grunwald"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Alan H. Schob"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Javier A. Valle"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Carlos E. Alfonso"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Brahmajee K. Nallamothu"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "P. Michael Ho"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "John S. Rumsfeld"], ["Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "Emmanouil S. Brilakis"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Cecilie Dahl"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Maggie Stanislawski"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Nina Iszatt"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Siddhartha Mandal"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Catherine Lozupone"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Jose C. Clemente"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Rob Knight"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Hein Stigum"], ["Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "Merete Eggesb\u00f8"], ["Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "Maggie Stanislawski"], ["Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "Dana Dabelea"], ["Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "Brandie D. Wagner"], ["Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "Marci K. Sontag"], ["Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "Catherine A. Lozupone"], ["Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "Merete Eggesb\u00f8"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Melissa M. Farmer"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Maggie Stanislawski"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Mary E. Plomondon"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Bevanne Bean-Mayberry"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Nataria T. Joseph"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Lauren E. Thompson"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Jessica L. Zuchowski"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Stacie L. Daugherty"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "Elizabeth M. Yano"], ["Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "P. Michael Ho"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Sian M.J. Hemmings"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Stefanie Malan-M\u00fcller"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Leigh L. van den Heuvel"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Brittany A. Demmitt"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Maggie Stanislawski"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "David G. Smith"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Adam D. Bohr"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Christopher E. Stamper"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Embriette R. Hyde"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "James T. Morton"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Clarisse A. Marotz"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Philip H. Siebler"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Maarten Braspenning"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Wim Van Criekinge"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Andrew J. Hoisington"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Lisa A. Brenner"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Teodor T. Postolache"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Matthew B. McQueen"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Kenneth S. Krauter"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Rob Knight"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Soraya Seedat"], ["The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "Christopher A. Lowry"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Amneet Sandhu"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Maggie Stanislawski"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Gary K. Grunwald"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Kathryn Guinn"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Javier Valle"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Daniel Matlock"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "P. Michael Ho"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Thomas M. Maddox"], ["Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "Steven M. Bradley"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Bradley A. Maron"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Edward Hess"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Thomas M. Maddox"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Alexander R. Opotowsky"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Ryan J. Tedford"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Tim Lahm"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Karen E. Joynt"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Daniel J. Kass"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Thomas Stephens"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Maggie Stanislawski"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Erik R. Swenson"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Ronald H. Goldstein"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Jane A. Leopold"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Roham T. Zamanian"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Jean M. Elwing"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Mary E. Plomondon"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Gary K. Grunwald"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Anna E. Bar\u00f3n"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "John S. Rumsfeld"], ["Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Gaurav Choudhary"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Westyn Branch-Elliman"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Maggie Stanislawski"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Judith Strymish"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Anna E. Bar\u00f3n"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Kalpana Gupta"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Paul D. Varosy"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "Howard S. Gold"], ["Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "P. Michael Ho"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Geoffrey D. Barnes"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Maggie Stanislawski"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Wenhui Liu"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Anna E. Bar\u00f3n"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Ehrin J. Armstrong"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "P. Michael Ho"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Andrew Klein"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Thomas M. Maddox"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Brahmajee K. Nallamothu"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "John S. Rumsfeld"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Thomas T. Tsai"], ["Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "Steven M. Bradley"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Steven M. Bradley"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Maggie Stanislawski"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "David B. Bekelman"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Lindsey L. Monteith"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Beth E. Cohen"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "John H. Schilling"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Stephen C. Hunt"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Debra Milek"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Thomas M. Maddox"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "P. Michael Ho"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Supriya Shore"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Paul D. Varosy"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "Monica M. Matthieu"], ["Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "John S. Rumsfeld"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Thomas M. Maddox"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Maggie Stanislawski"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Gary K. Grunwald"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Steven M. Bradley"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "P. Michael Ho"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Thomas T. Tsai"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Manesh R. Patel"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Amneet Sandhu"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Javier Valle"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "David J. Magid"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Benjamin Leon"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Deepak L. Bhatt"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "Stephan D. Fihn"], ["Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "John S. Rumsfeld"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Steven M. Bradley"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Thomas M. Maddox"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Maggie Stanislawski"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Colin I. O\u2019Donnell"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Gary K. Grunwald"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Thomas T. Tsai"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "P. Michael Ho"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "Eric D. Peterson"], ["Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "John S. Rumsfeld"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Thomas M. Maddox"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Maggie Stanislawski"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Colin O\u2019Donnell"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Mary E. Plomondon"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Steven M. Bradley"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "P. Michael Ho"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Thomas T. Tsai"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Adhir R. Shroff"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Bernadette Speiser"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "Robert J. Jesse"], ["Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "John S. Rumsfeld"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Vikas Aggarwal"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Maggie Stanislawski"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Thomas M. Maddox"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Brahmajee K. Nallamothu"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Gary Grunwald"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Jill C. Adams"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "P. Michael Ho"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Sunil V. Rao"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Ivan P. Casserly"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "John S. Rumsfeld"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Emmanouil S. Brilakis"], ["Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "Thomas T. Tsai"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Antonio Gutierrez"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Thomas T. Tsai"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Maggie Stanislawski"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Mladen Vidovich"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Christopher L. Bryson"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Deepak L. Bhatt"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Gary K. Grunwald"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "John Rumsfeld"], ["Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "Sunil V. Rao"], ["CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics", "Jade Young"], ["CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics", "Jun Inamo"], ["CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics", "Zachary Caterer"], ["CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics", "Revanth Krishna"], ["CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics", "Fan Zhang"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Zachary Caterer"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Rachel V. Horejsi"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Carly Weber"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Blake Mathisen"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Chase N. Nelson"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Maggie Bagatta"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Ireland Coughlin"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Megan Wettstein"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Ankit Kulshrestha"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Hui Siang Benjamin Lee"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Leonardo R. Nunn"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Mostafa Zamanian"], ["A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "Nicolas J. Wheeler"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Zachary Caterer"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Jordan Langlois"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Connor McKeown"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Mikayla Hady"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Samuel Stumo"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Suman Setty"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Michael Walsh"], ["Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "Rahul Gomes"], ["CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics", "Jade Young"], ["CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics", "Jun Inamo"], ["CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics", "Zachary Caterer"], ["CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics", "Revanth Krishna"], ["CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics", "Fan Zhang"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Felicia Ebot-Ojong"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Aileen R. Ferraro"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Rochelle E. Yap"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Farh Kaddar"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Clayton Hull-Crew"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Ashley Scadden"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Abigail M. Deaven"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Andrew D. Klocko"], ["HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "Zachary A. Lewis"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Aastha Kakar"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Elizabeth M. Litkowski"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Ashley Scadden"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Mohammad Y. Anwar"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Iain R. Konigsberg"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Maggie Stanislawski"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Natalie C. DuPre"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Riten Mitra"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Richard Baumgartner"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Laura M. Raffield"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Ethan M. Lange"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Leslie A. Lange"], ["A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "Kira C. Taylor"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Xinruo Zhang"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Ashley Scadden"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Amarnath Marthi"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Victoria L. Buchanan"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Yishu Qu"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Kendra R. Ferrier"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Brian D. Chen"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Mariaelisa Graff"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Julian Avila"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Eric Boerwinkle"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Steven Buyske"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Clary B. Clish"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Dan Cruz"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Myriam Fornage"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Robert E. Gerzsten"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Christopher R. Gignoux"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "LaShaunta Glover"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Lifang Hou"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Anne E. Justice"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Charles Kooperberg"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Holly Kramer"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Leslie Lange"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Ruth J.F. Loos"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Tara Matise"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Josyf C. Mychaleckyj"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Opeyemi A. Olabisi"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Ulrike Peters"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Laura M. Raffield"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Alex P. Reiner"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Stephen S. Rich"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Jerome I. Rotter"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Kent D. Taylor"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Bing Yu"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Yinan Zheng"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Kari E. North"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Amy K. Mottl"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Heather M. Highland"], ["Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "Maggie Stanislawski"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Ashley Scadden"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Aastha Kakar"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Elizabeth M. Litkowski"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Mariah C. Meyer"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Nicole D. Armstrong"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Steven Buyske"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Yanwei Cai"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Iona Cheng"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Burcu F. Darst"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Myriam Fornage"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Mariaelisa Graff"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Boya Guo"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Christopher A. Haiman"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Heather M. Highland"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Charles Kooperberg"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Lo\u00efc Le Marchand"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Kari North"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Ulrike Peters"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Stephen S. Rich"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Jerome I. Rotter"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Vinodh Srinivasasainagendra"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Hemant K. Tiwari"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Stephanie Waldrop"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Kristin Young"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Sridharan Raghavan"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Ethan M. Lange"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Leslie A. Lange"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Marguerite R. Irvin"], ["Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "Maggie Stanislawski"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Felicia Ebot-Ojong"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Aileen R. Ferraro"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Farh Kaddar"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Clayton Hull-Crew"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Ashley Scadden"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Andrew D. Klocko"], ["Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "Zachary A. Lewis"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "Ashley Scadden"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "Alayne S. Graybill"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "Clayton Hull-Crew"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "Tiffany J. Lundberg"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "Nickolas M. Lande"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "Andrew D. Klocko"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "Ashley Scadden"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "Alayne S. Graybill"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "Clayton Hull-Crew"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "Tiffany J. Lundberg"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "Nickolas M. Lande"], ["Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "Andrew D. Klocko"], ["The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "Sara Rodriguez"], ["The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "Ashley Scadden"], ["The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "Andrew T Reckard"], ["The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "Yulia Shtanko"], ["The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "Clayton Hull-Crew"], ["The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "Andrew D Klocko"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Emily Yeo"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Nathan D. Young"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Joseph C. Cleveland"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Tamara D. Simon"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Douglas L. Vanderbilt"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Juan Espinoza"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Christine B. Mirzaian"], ["High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "Tanya L. Alderete"], ["Hospitalization throws the preterm gut microbiome off-key", "Jing Qian"], ["Hospitalization throws the preterm gut microbiome off-key", "Emily Yeo"], ["Hospitalization throws the preterm gut microbiome off-key", "Matthew R. Olm"], ["Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice", "Ying Zhu"], ["Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice", "Emily Yeo"], ["Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice", "Kelsey M Smith"], ["Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice", "Andrew S Greenberg"], ["Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice", "Sheldon Rowan"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Bridget Chalifour"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Elizabeth A. Holzhausen"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Joseph J. Lim"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Emily Yeo"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Natalie Shen"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Dean P. Jones"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Bradley S. Peterson"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Michael I. Goran"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Donghai Liang"], ["The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "Tanya L. Alderete"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "M\u00fcge Sak"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Brian J. Williams"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Cory T. Zumbar"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Landon Teer"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Mustafa N. G. Al-Kawaaz"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Aastha Kakar"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Andrew J. Hey"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Megan J. Wilson"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Leslie M. Schier"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Joseph Chen"], ["The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "Norman L. Lehman"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Maggie Stanislawski"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Daniel N. Frank"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Sarah J. Borengasser"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Danielle M. Ostendorf"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Diana Ir"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Purevsuren Jambal"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Kristen Bing"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Liza Wayland"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Janet C. Siebert"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Daniel H. Bessesen"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Paul S. MacLean"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Edward L. Melanson"], ["The Gut Microbiota during a Behavioral Weight Loss Intervention", "Victoria A. Catenacci"]], "nodes": {"Modeling the genomic architecture of adiposity and anthropometrics across the lifespan": {"name": "Modeling the genomic architecture of adiposity and anthropometrics across the lifespan", "kind": "paper", "url": "https://doi.org/g9x39m", "size": 0.7, "color": "#1C7BE0"}, "Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.": {"name": "Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/40451158", "size": 0.7, "color": "#1C7BE0"}, "Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.": {"name": "Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/40193202", "size": 0.7, "color": "#1C7BE0"}, "A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals": {"name": "A multi-ethnic polygenic risk score for chronic kidney disease is associated with increased risk of hypertension in African American individuals", "kind": "paper", "url": "https://doi.org/g95wqj", "size": 0.7, "color": "#1C7BE0"}, "Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults": {"name": "Ancestry Calibration of Polygenic Risk Scores Improves Risk Stratification and Effect Estimation in African American Adults", "kind": "paper", "url": "https://doi.org/g9q9fd", "size": 0.7, "color": "#1C7BE0"}, "Epigenome-wide association study meta-analysis of BMI in African American Adults": {"name": "Epigenome-wide association study meta-analysis of BMI in African American Adults", "kind": "paper", "url": "https://doi.org/g9x39p", "size": 0.7, "color": "#1C7BE0"}, "Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns": {"name": "Machine learning\u2010based clustering identifies obesity subgroups with differential multi\u2010omics profiles and metabolic patterns", "kind": "paper", "url": "https://doi.org/g9x39q", "size": 0.7, "color": "#1C7BE0"}, "EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies": {"name": "EXPLANA: A user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies", "kind": "paper", "url": "https://doi.org/g9q9dk", "size": 0.7, "color": "#1C7BE0"}, "Poly-omic risk scores predict inflammatory bowel disease diagnosis.": {"name": "Poly-omic risk scores predict inflammatory bowel disease diagnosis.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/38095449", "size": 0.7, "color": "#1C7BE0"}, "Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review": {"name": "Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review", "kind": "paper", "url": "https://doi.org/g9q9dm", "size": 0.7, "color": "#1C7BE0"}, "Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification": {"name": "Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification", "kind": "paper", "url": "https://doi.org/gss9wh", "size": 0.7, "color": "#1C7BE0"}, "The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss": {"name": "The Microbiome, Epigenome, and Diet in Adults with Obesity during Behavioral Weight Loss", "kind": "paper", "url": "https://doi.org/gtt6d8", "size": 0.7, "color": "#1C7BE0"}, "Human microbiome transfer in the built environment differs based on occupants, objects, and buildings": {"name": "Human microbiome transfer in the built environment differs based on occupants, objects, and buildings", "kind": "paper", "url": "https://doi.org/g9x39r", "size": 0.7, "color": "#1C7BE0"}, "Poly-omic risk scores predict inflammatory bowel disease diagnosis": {"name": "Poly-omic risk scores predict inflammatory bowel disease diagnosis", "kind": "paper", "url": "https://doi.org/g9q9dn", "size": 0.7, "color": "#1C7BE0"}, "The Gut Microbiota during a Behavioral Weight Loss Intervention.": {"name": "The Gut Microbiota during a Behavioral Weight Loss Intervention.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/34579125", "size": 0.7, "color": "#1C7BE0"}, "Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.": {"name": "Characterization of the gut microbiota among Veterans with unique military-related exposures and high prevalence of chronic health conditions: A United States-Veteran Microbiome Project (US-VMP) study.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/34988495", "size": 0.7, "color": "#1C7BE0"}, "Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.": {"name": "Genetic Risk Score for Type 2 Diabetes and Traits Related to Glucose-Insulin Homeostasis in Youth: The Exploring Perinatal Outcomes Among Children (EPOCH) Study.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/34257098", "size": 0.7, "color": "#1C7BE0"}, "Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.": {"name": "Associations of Nutrient Intake Changes During Childhood with Adolescent Hepatic Fat: The Exploring Perinatal Outcomes Among CHildren\u00a0Study.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/34171361", "size": 0.7, "color": "#1C7BE0"}, "Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.": {"name": "Genetic Interactions with Intrauterine Diabetes Exposure in Relation to Obesity: The EPOCH and Project Viva Studies.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/34205853", "size": 0.7, "color": "#1C7BE0"}, "Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.": {"name": "Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/33910371", "size": 0.7, "color": "#1C7BE0"}, "Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.": {"name": "Multiomic Predictors of Short-Term Weight Loss and Clinical Outcomes During a Behavioral-Based Weight Loss Intervention.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/33811477", "size": 0.7, "color": "#1C7BE0"}, "Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)": {"name": "Dietary habits and the gut microbiota in military Veterans: results from the United States-Veteran Microbiome Project (US-VMP)", "kind": "paper", "url": "https://doi.org/g9q9dp", "size": 0.7, "color": "#1C7BE0"}, "Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.": {"name": "Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/32881767", "size": 0.7, "color": "#1C7BE0"}, "Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.": {"name": "Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/32495698", "size": 0.7, "color": "#1C7BE0"}, "Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.": {"name": "Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/32345254", "size": 0.7, "color": "#1C7BE0"}, "Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.": {"name": "Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/32210289", "size": 0.7, "color": "#1C7BE0"}, "Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.": {"name": "Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/32143931", "size": 0.7, "color": "#1C7BE0"}, "Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.": {"name": "Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/32000780", "size": 0.7, "color": "#1C7BE0"}, "Gut microbiota phenotypes of obesity.": {"name": "Gut microbiota phenotypes of obesity.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/31285833", "size": 0.7, "color": "#1C7BE0"}, "Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.": {"name": "Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/31159895", "size": 0.7, "color": "#1C7BE0"}, "Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d": {"name": "Reply to Moossavi and Azad, \u201cQuantifying and Interpreting the Association between Early-Life Gut Microbiota Composition and Childhood Obesity\u201d", "kind": "paper", "url": "https://doi.org/g9q9dq", "size": 0.7, "color": "#1C7BE0"}, "Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.": {"name": "Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/30358654", "size": 0.7, "color": "#1C7BE0"}, "Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).": {"name": "Military-Related Exposures, Social Determinants of Health, and Dysbiosis: The United States-Veteran Microbiome Project (US-VMP).", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/30510919", "size": 0.7, "color": "#1C7BE0"}, "Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.": {"name": "Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/30396358", "size": 0.7, "color": "#1C7BE0"}, "Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.": {"name": "Gut Microbiota in the First 2 Years of Life and the Association with Body Mass Index at Age 12 in a Norwegian Birth Cohort.", "kind": "paper", "url": "https://www.ncbi.nlm.nih.gov/pubmed/30352933", "size": 0.7, "color": "#1C7BE0"}, "Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program": {"name": "Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program", "kind": "paper", "url": "https://doi.org/g9q9dr", "size": 0.7, "color": "#1C7BE0"}, "Maggie Stanislawski\u2014August ECI biocommentary": {"name": "Maggie Stanislawski\u2014August ECI biocommentary", "kind": "paper", "url": "https://doi.org/g9q9ds", "size": 0.7, "color": "#1C7BE0"}, "Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program": {"name": "Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program", "kind": "paper", "url": "https://doi.org/gd95mq", "size": 0.7, "color": "#1C7BE0"}, "The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program": {"name": "The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program", "kind": "paper", "url": "https://doi.org/g9q9dt", "size": 0.7, "color": "#1C7BE0"}, "Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program": {"name": "Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End\u2010Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization\u2014An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program", "kind": "paper", "url": "https://doi.org/gfhx2s", "size": 0.7, "color": "#1C7BE0"}, "Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions": {"name": "Contemporary Incidence, Management, and\u00a0Long-Term Outcomes of Percutaneous\u00a0Coronary Interventions for Chronic\u00a0Coronary Artery Total Occlusions", "kind": "paper", "url": "https://doi.org/g9q9dv", "size": 0.7, "color": "#1C7BE0"}, "Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus": {"name": "Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus", "kind": "paper", "url": "https://doi.org/gcf7cg", "size": 0.7, "color": "#1C7BE0"}, "Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants": {"name": "Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants", "kind": "paper", "url": "https://doi.org/gbxcbg", "size": 0.7, "color": "#1C7BE0"}, "Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration": {"name": "Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration", "kind": "paper", "url": "https://doi.org/gcfv7f", "size": 0.7, "color": "#1C7BE0"}, "The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study": {"name": "The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study", "kind": "paper", "url": "https://doi.org/gcf55k", "size": 0.7, "color": "#1C7BE0"}, "Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program": {"name": "Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program", "kind": "paper", "url": "https://doi.org/g77m3d", "size": 0.7, "color": "#1C7BE0"}, "Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program": {"name": "Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "kind": "paper", "url": "https://doi.org/f8g572", "size": 0.7, "color": "#1C7BE0"}, "Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?": {"name": "Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?", "kind": "paper", "url": "https://doi.org/f834x4", "size": 0.7, "color": "#1C7BE0"}, "Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention": {"name": "Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention", "kind": "paper", "url": "https://doi.org/f8xcbz", "size": 0.7, "color": "#1C7BE0"}, "Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program": {"name": "Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program", "kind": "paper", "url": "https://doi.org/f6f5v3", "size": 0.7, "color": "#1C7BE0"}, "Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction": {"name": "Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction", "kind": "paper", "url": "https://doi.org/cjhg", "size": 0.7, "color": "#1C7BE0"}, "Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System": {"name": "Normal Coronary Rates for Elective Angiography in the Veterans Affairs Healthcare System", "kind": "paper", "url": "https://doi.org/f2qrkm", "size": 0.7, "color": "#1C7BE0"}, "Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery": {"name": "Patient Access and 1-Year Outcomes of Percutaneous Coronary Intervention Facilities With and Without On-Site Cardiothoracic Surgery", "kind": "paper", "url": "https://doi.org/f6m62p", "size": 0.7, "color": "#1C7BE0"}, "Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions": {"name": "Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions", "kind": "paper", "url": "https://doi.org/f2vs47", "size": 0.7, "color": "#1C7BE0"}, "Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System": {"name": "Adoption of Transradial Percutaneous Coronary Intervention and Outcomes According to Center Radial Volume in the Veterans Affairs Healthcare System", "kind": "paper", "url": "https://doi.org/f47rp6", "size": 0.7, "color": "#1C7BE0"}, "CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics": {"name": "CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single\u2010Cell Multi\u2010Omics", "kind": "paper", "url": "https://doi.org/g94kfq", "size": 0.7, "color": "#1C7BE0"}, "A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening": {"name": "A graphical user interface for wrmXpress 2.0 streamlines helminth phenotypic screening", "kind": "paper", "url": "https://doi.org/g9q9d2", "size": 0.7, "color": "#1C7BE0"}, "Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging": {"name": "Exploring Feature Selection with Deep Learning for Kidney Tissue Microarray Classification Using Infrared Spectral Imaging", "kind": "paper", "url": "https://doi.org/g9q9d3", "size": 0.7, "color": "#1C7BE0"}, "CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics": {"name": "CellPhenoX: An eXplainable Cell-specific machine learning method to predict clinical Phenotypes using single-cell multi-omics", "kind": "paper", "url": "https://doi.org/g9q9d4", "size": 0.7, "color": "#1C7BE0"}, "HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>": {"name": "HISTONE DEACETYLASE-1 is required for epigenome stability in\n            <i>Neurospora crassa</i>", "kind": "paper", "url": "https://doi.org/g95wqh", "size": 0.7, "color": "#1C7BE0"}, "Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles": {"name": "Alterations in DNA Methylation, Proteomic, and Metabolomic Profiles in African Ancestry Populations with APOL1 Risk Alleles", "kind": "paper", "url": "https://doi.org/g9q9d5", "size": 0.7, "color": "#1C7BE0"}, "Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans": {"name": "Type 2 diabetes polygenic risk score interactions with lifestyle risk factors in Black Americans", "kind": "paper", "url": "https://doi.org/g9sgz4", "size": 0.7, "color": "#1C7BE0"}, "Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>": {"name": "Histone deacetylase-1 is required for epigenome stability in <i>Neurospora crassa</i>", "kind": "paper", "url": "https://doi.org/g9q9d6", "size": 0.7, "color": "#1C7BE0"}, "Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>": {"name": "Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of\n            <i>Neurospora crassa</i>", "kind": "paper", "url": "https://doi.org/g9q9d7", "size": 0.7, "color": "#1C7BE0"}, "Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>": {"name": "Histone deacetylation and cytosine methylation compartmentalize heterochromatic regions in the genome organization of<i>Neurospora crassa</i>", "kind": "paper", "url": "https://doi.org/g9q9d8", "size": 0.7, "color": "#1C7BE0"}, "The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology": {"name": "The genome organization of <i>Neurospora crassa</i> at high resolution uncovers principles of fungal chromosome topology", "kind": "paper", "url": "https://doi.org/g6p2m2", "size": 0.7, "color": "#1C7BE0"}, "High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity": {"name": "High-Risk Infant Developmental Outcome Is Associated with Medical Complexity and Neighborhood Opportunity", "kind": "paper", "url": "https://doi.org/g9q9fb", "size": 0.7, "color": "#1C7BE0"}, "Hospitalization throws the preterm gut microbiome off-key": {"name": "Hospitalization throws the preterm gut microbiome off-key", "kind": "paper", "url": "https://doi.org/g9q9fc", "size": 0.7, "color": "#1C7BE0"}, "Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice": {"name": "Aging Modulates the Effect of Dietary Glycemic Index on Gut Microbiota Composition in Mice", "kind": "paper", "url": "https://doi.org/g8wc7m", "size": 0.7, "color": "#1C7BE0"}, "The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes": {"name": "The potential role of early life feeding patterns in shaping the infant fecal metabolome: implications for neurodevelopmental outcomes", "kind": "paper", "url": "https://doi.org/gs8wz2", "size": 0.7, "color": "#1C7BE0"}, "The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo": {"name": "The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo", "kind": "paper", "url": "https://doi.org/g9sgz5", "size": 0.7, "color": "#1C7BE0"}, "The Gut Microbiota during a Behavioral Weight Loss Intervention": {"name": "The Gut Microbiota during a Behavioral Weight Loss Intervention", "kind": "paper", "url": "https://doi.org/gsgh8k", "size": 0.7, "color": "#1C7BE0"}, "Zachary Caterer": {"kind": "lab member", "name": "Zachary Caterer", "size": 2.0, "color": "#E01E7B"}, "Emily Yeo": {"kind": "lab member", "name": "Emily Yeo", "size": 2.0, "color": "#E01E7B"}, "Ashley Scadden": {"kind": "lab member", "name": "Ashley Scadden", "size": 2.0, "color": "#E01E7B"}, "Maggie Stanislawski": {"kind": "lab member", "name": "Maggie Stanislawski", "size": 2.0, "color": "#E01E7B"}, "Aastha Kakar": {"kind": "lab member", "name": "Aastha Kakar", "size": 2.0, "color": "#E01E7B"}, "Christopher H. Arehart": {"name": "Christopher H. Arehart", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Meng Lin": {"name": "Meng Lin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Raine A. Gibson": {"name": "Raine A. Gibson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Heather D. Anderson": {"name": "Heather D. Anderson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christina L. Aquilante": {"name": "Christina L. Aquilante", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kelsey Arbogast": {"name": "Kelsey Arbogast", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ian M. Brooks": {"name": "Ian M. Brooks", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tonya M. Brunetti": {"name": "Tonya M. Brunetti", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Judith Brutus-Lestin": {"name": "Judith Brutus-Lestin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elizabeth E. Burke": {"name": "Elizabeth E. Burke", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily M. Casteel": {"name": "Emily M. Casteel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joanne B. Cole": {"name": "Joanne B. Cole", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Curtis R. Coughlin": {"name": "Curtis R. Coughlin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kristy Crooks": {"name": "Kristy Crooks", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jacob Crawford": {"name": "Jacob Crawford", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Erin Culver": {"name": "Erin Culver", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michelle N. Edelmann": {"name": "Michelle N. Edelmann", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Matthew J. Fisher": {"name": "Matthew J. Fisher", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alan W. Franklin": {"name": "Alan W. Franklin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Teresa C. Frye": {"name": "Teresa C. Frye", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hunter George": {"name": "Hunter George", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christopher R. Gignoux": {"name": "Christopher R. Gignoux", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Elizabeth K. Gilliland": {"name": "Elizabeth K. Gilliland", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Casey S. Greene": {"name": "Casey S. Greene", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brooke Hawkes": {"name": "Brooke Hawkes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily Hearst": {"name": "Emily Hearst", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Audrey E. Hendricks": {"name": "Audrey E. Hendricks", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Randi K. Johnson": {"name": "Randi K. Johnson", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Colleen G. Julian": {"name": "Colleen G. Julian", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dave Kao": {"name": "Dave Kao", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Iain Konigsberg": {"name": "Iain Konigsberg", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lisa Ku": {"name": "Lisa Ku", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elizabeth L. Kudron": {"name": "Elizabeth L. Kudron", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rashawnda Lacy": {"name": "Rashawnda Lacy", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ethan M. Lange": {"name": "Ethan M. Lange", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Yee Ming Lee": {"name": "Yee Ming Lee", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joe A. Lesny": {"name": "Joe A. Lesny", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jan T. Lowery": {"name": "Jan T. Lowery", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Luciana B. Vargas": {"name": "Luciana B. Vargas", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Betzaida L. Maldonado": {"name": "Betzaida L. Maldonado", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Darcy Marceau": {"name": "Darcy Marceau", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "James L. Martin": {"name": "James L. Martin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brianna L. Gates": {"name": "Brianna L. Gates", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "David Mayer": {"name": "David Mayer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nicole L. McDaniel": {"name": "Nicole L. McDaniel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew Monte": {"name": "Andrew Monte", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ethan Moore": {"name": "Ethan Moore", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ann Nadrash": {"name": "Ann Nadrash", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jack Pattee": {"name": "Jack Pattee", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nikita Pozdeyev": {"name": "Nikita Pozdeyev", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alaa Radwan": {"name": "Alaa Radwan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nick Rafaels": {"name": "Nick Rafaels", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sridharan Raghavan": {"name": "Sridharan Raghavan", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Neda Rasouli": {"name": "Neda Rasouli", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elise L. Shalowitz": {"name": "Elise L. Shalowitz", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hoda Sherif": {"name": "Hoda Sherif", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Johnathan A. Shortt": {"name": "Johnathan A. Shortt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adrian M. Stewart": {"name": "Adrian M. Stewart", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kristen J. Sutton": {"name": "Kristen J. Sutton", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Carolyn T. Swartz": {"name": "Carolyn T. Swartz", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anna Tanaka": {"name": "Anna Tanaka", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Matthew R. G. Taylor": {"name": "Matthew R. G. Taylor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Candace Teague": {"name": "Candace Teague", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily B. Todd": {"name": "Emily B. Todd", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katy E. Trinkley": {"name": "Katy E. Trinkley", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Laura K. Wiley": {"name": "Laura K. Wiley", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew D. Grotzinger": {"name": "Andrew D. Grotzinger", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Luke M. Evans": {"name": "Luke M. Evans", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Elizabeth M Litkowski": {"name": "Elizabeth M Litkowski", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mariah C Meyer": {"name": "Mariah C Meyer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nicole D Armstrong": {"name": "Nicole D Armstrong", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Steven Buyske": {"name": "Steven Buyske", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Yanwei Cai": {"name": "Yanwei Cai", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Iona Cheng": {"name": "Iona Cheng", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Burcu F Darst": {"name": "Burcu F Darst", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Myriam Fornage": {"name": "Myriam Fornage", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Mariaelisa Graff": {"name": "Mariaelisa Graff", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Boya Guo": {"name": "Boya Guo", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Christopher A Haiman": {"name": "Christopher A Haiman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Heather M Highland": {"name": "Heather M Highland", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Charles Kooperberg": {"name": "Charles Kooperberg", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Lo\u00efc Le Marchand": {"name": "Lo\u00efc Le Marchand", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kari North": {"name": "Kari North", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Ulrike Peters": {"name": "Ulrike Peters", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Stephen S Rich": {"name": "Stephen S Rich", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jerome I Rotter": {"name": "Jerome I Rotter", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Vinodh Srinivasasainagendra": {"name": "Vinodh Srinivasasainagendra", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Hemant K Tiwari": {"name": "Hemant K Tiwari", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephanie Waldrop": {"name": "Stephanie Waldrop", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kristin Young": {"name": "Kristin Young", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Ethan M Lange": {"name": "Ethan M Lange", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Leslie A Lange": {"name": "Leslie A Lange", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Marguerite R Irvin": {"name": "Marguerite R Irvin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Xinruo Zhang": {"name": "Xinruo Zhang", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Amarnath Marthi": {"name": "Amarnath Marthi", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Victoria L Buchanan": {"name": "Victoria L Buchanan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yishu Qu": {"name": "Yishu Qu", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kendra R Ferrier": {"name": "Kendra R Ferrier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brian D Chen": {"name": "Brian D Chen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Julian Avila": {"name": "Julian Avila", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Eric Boerwinkle": {"name": "Eric Boerwinkle", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Clary B Clish": {"name": "Clary B Clish", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dan Cruz": {"name": "Dan Cruz", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Robert E Gerzsten": {"name": "Robert E Gerzsten", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christopher R Gignoux": {"name": "Christopher R Gignoux", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "LaShaunta Glover": {"name": "LaShaunta Glover", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Lifang Hou": {"name": "Lifang Hou", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Anne E Justice": {"name": "Anne E Justice", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Holly Kramer": {"name": "Holly Kramer", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Leslie Lange": {"name": "Leslie Lange", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Ruth J F Loos": {"name": "Ruth J F Loos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tara Matise": {"name": "Tara Matise", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Josyf C Mychaleckyj": {"name": "Josyf C Mychaleckyj", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Opeyemi A Olabisi": {"name": "Opeyemi A Olabisi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Laura M Raffield": {"name": "Laura M Raffield", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Alex P Reiner": {"name": "Alex P Reiner", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kent D Taylor": {"name": "Kent D Taylor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bing Yu": {"name": "Bing Yu", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Yinan Zheng": {"name": "Yinan Zheng", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kari E North": {"name": "Kari E North", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Amy K Mottl": {"name": "Amy K Mottl", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elizabeth M. Litkowski": {"name": "Elizabeth M. Litkowski", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Mohammad Y. Anwar": {"name": "Mohammad Y. Anwar", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Iain R. Konigsberg": {"name": "Iain R. Konigsberg", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Natalie C. DuPre": {"name": "Natalie C. DuPre", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Riten Mitra": {"name": "Riten Mitra", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Richard Baumgartner": {"name": "Richard Baumgartner", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Laura M. Raffield": {"name": "Laura M. Raffield", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Leslie A. Lange": {"name": "Leslie A. Lange", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Kira C. Taylor": {"name": "Kira C. Taylor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mariah C. Meyer": {"name": "Mariah C. Meyer", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Patrick M. Carry": {"name": "Patrick M. Carry", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yun Li": {"name": "Yun Li", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alana C. Jones": {"name": "Alana C. Jones", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hemant K. Tiwari": {"name": "Hemant K. Tiwari", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Nicole D. Armstrong": {"name": "Nicole D. Armstrong", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Eimear E. Kenny": {"name": "Eimear E. Kenny", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bogdan Pasaniuc": {"name": "Bogdan Pasaniuc", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marguerite R. Irvin": {"name": "Marguerite R. Irvin", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Michael H. Cho": {"name": "Michael H. Cho", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jonathan A. Shortt": {"name": "Jonathan A. Shortt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kendra Ferrier": {"name": "Kendra Ferrier", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Heather M. Highland": {"name": "Heather M. Highland", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "April P. Carson": {"name": "April P. Carson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jill M. Norris": {"name": "Jill M. Norris", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chris R. Gignoux": {"name": "Chris R. Gignoux", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kari E. North": {"name": "Kari E. North", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Matthew A. Allison": {"name": "Matthew A. Allison", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mathew J. Budoff": {"name": "Mathew J. Budoff", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Silva Kasela": {"name": "Silva Kasela", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Fran\u00e7ois Aguet": {"name": "Fran\u00e7ois Aguet", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joshua J. Joseph": {"name": "Joshua J. Joseph", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephen S. Rich": {"name": "Stephen S. Rich", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Jerome I. Rotter": {"name": "Jerome I. Rotter", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Heather Highland": {"name": "Heather Highland", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Victoria Lynn Buchanan": {"name": "Victoria Lynn Buchanan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kent D. Taylor": {"name": "Kent D. Taylor", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Russell P. Tracy": {"name": "Russell P. Tracy", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Peter Durda": {"name": "Peter Durda", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yongmei Liu": {"name": "Yongmei Liu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Craig W. Johnson": {"name": "Craig W. Johnson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Francois Aguet": {"name": "Francois Aguet", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kristin G. Ardlie": {"name": "Kristin G. Ardlie", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert E. Gerszten": {"name": "Robert E. Gerszten", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Clary B. Clish": {"name": "Clary B. Clish", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jingzhong Ding": {"name": "Jingzhong Ding", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mark O. Goodarzi": {"name": "Mark O. Goodarzi", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Yii\u2010Der Ida Chen": {"name": "Yii\u2010Der Ida Chen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gina M. Peloso": {"name": "Gina M. Peloso", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Xiuqing Guo": {"name": "Xiuqing Guo", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Anne E. Justice": {"name": "Anne E. Justice", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Ching\u2010ti Liu": {"name": "Ching\u2010ti Liu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jennifer Fouquier": {"name": "Jennifer Fouquier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John O\u2019Connor": {"name": "John O\u2019Connor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Catherine Lozupone": {"name": "Catherine Lozupone", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Christopher H Arehart": {"name": "Christopher H Arehart", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John D Sterrett": {"name": "John D Sterrett", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rosanna L Garris": {"name": "Rosanna L Garris", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ruth E Quispe-Pilco": {"name": "Ruth E Quispe-Pilco", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Luke M Evans": {"name": "Luke M Evans", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katherine G. Young": {"name": "Katherine G. Young", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Eram Haider McInnes": {"name": "Eram Haider McInnes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert J. Massey": {"name": "Robert J. Massey", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anna R. Kahkoska": {"name": "Anna R. Kahkoska", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Scott J. Pilla": {"name": "Scott J. Pilla", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Deirdre K. Tobias": {"name": "Deirdre K. Tobias", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew P. McGovern": {"name": "Andrew P. McGovern", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adem Y. Dawed": {"name": "Adem Y. Dawed", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Angus G. Jones": {"name": "Angus G. Jones", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ewan R. Pearson": {"name": "Ewan R. Pearson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John M. Dennis": {"name": "John M. Dennis", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jordi Merino": {"name": "Jordi Merino", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Abrar Ahmad": {"name": "Abrar Ahmad", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Catherine Aiken": {"name": "Catherine Aiken", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jamie L. Benham": {"name": "Jamie L. Benham", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dhanasekaran Bodhini": {"name": "Dhanasekaran Bodhini", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Amy L. Clark": {"name": "Amy L. Clark", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kevin Colclough": {"name": "Kevin Colclough", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rosa Corcoy": {"name": "Rosa Corcoy", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sara J. Cromer": {"name": "Sara J. Cromer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daisy Duan": {"name": "Daisy Duan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jamie L. Felton": {"name": "Jamie L. Felton", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ellen C. Francis": {"name": "Ellen C. Francis", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Pieter Gillard": {"name": "Pieter Gillard", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "V\u00e9ronique Gingras": {"name": "V\u00e9ronique Gingras", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Romy Gaillard": {"name": "Romy Gaillard", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Eram Haider": {"name": "Eram Haider", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alice Hughes": {"name": "Alice Hughes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jennifer M. Ikle": {"name": "Jennifer M. Ikle", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Laura M. Jacobsen": {"name": "Laura M. Jacobsen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jarno L. T. Kettunen": {"name": "Jarno L. T. Kettunen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Raymond J. Kreienkamp": {"name": "Raymond J. Kreienkamp", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lee-Ling Lim": {"name": "Lee-Ling Lim", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jonna M. E. M\u00e4nnist\u00f6": {"name": "Jonna M. E. M\u00e4nnist\u00f6", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert Massey": {"name": "Robert Massey", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Niamh-Maire Mclennan": {"name": "Niamh-Maire Mclennan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rachel G. Miller": {"name": "Rachel G. Miller", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mario Luca Morieri": {"name": "Mario Luca Morieri", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jasper Most": {"name": "Jasper Most", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rochelle N. Naylor": {"name": "Rochelle N. Naylor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bige Ozkan": {"name": "Bige Ozkan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kashyap Amratlal Patel": {"name": "Kashyap Amratlal Patel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katsiaryna Prystupa": {"name": "Katsiaryna Prystupa", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sridaran Raghaven": {"name": "Sridaran Raghaven", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mary R. Rooney": {"name": "Mary R. Rooney", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Martin Sch\u00f6n": {"name": "Martin Sch\u00f6n", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Zhila Semnani-Azad": {"name": "Zhila Semnani-Azad", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Magdalena Sevilla-Gonzalez": {"name": "Magdalena Sevilla-Gonzalez", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Pernille Svalastoga": {"name": "Pernille Svalastoga", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wubet Worku Takele": {"name": "Wubet Worku Takele", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Claudia Ha-ting Tam": {"name": "Claudia Ha-ting Tam", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anne Cathrine B. Thuesen": {"name": "Anne Cathrine B. Thuesen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mustafa Tosur": {"name": "Mustafa Tosur", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Amelia S. Wallace": {"name": "Amelia S. Wallace", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Caroline C. Wang": {"name": "Caroline C. Wang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jessie J. Wong": {"name": "Jessie J. Wong", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jennifer M. Yamamoto": {"name": "Jennifer M. Yamamoto", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katherine Young": {"name": "Katherine Young", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chlo\u00e9 Amouyal": {"name": "Chlo\u00e9 Amouyal", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mette K. Andersen": {"name": "Mette K. Andersen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maxine P. Bonham": {"name": "Maxine P. Bonham", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mingling Chen": {"name": "Mingling Chen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Feifei Cheng": {"name": "Feifei Cheng", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tinashe Chikowore": {"name": "Tinashe Chikowore", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sian C. Chivers": {"name": "Sian C. Chivers", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christoffer Clemmensen": {"name": "Christoffer Clemmensen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dana Dabelea": {"name": "Dana Dabelea", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Aaron J. Deutsch": {"name": "Aaron J. Deutsch", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Laura T. Dickens": {"name": "Laura T. Dickens", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Linda A. DiMeglio": {"name": "Linda A. DiMeglio", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Monika Dudenh\u00f6ffer-Pfeifer": {"name": "Monika Dudenh\u00f6ffer-Pfeifer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Carmella Evans-Molina": {"name": "Carmella Evans-Molina", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mar\u00eda Merc\u00e8 Fern\u00e1ndez-Balsells": {"name": "Mar\u00eda Merc\u00e8 Fern\u00e1ndez-Balsells", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hugo Fitipaldi": {"name": "Hugo Fitipaldi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephanie L. Fitzpatrick": {"name": "Stephanie L. Fitzpatrick", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephen E. Gitelman": {"name": "Stephen E. Gitelman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jessica A. Grieger": {"name": "Jessica A. Grieger", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marta Guasch-Ferr\u00e9": {"name": "Marta Guasch-Ferr\u00e9", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nahal Habibi": {"name": "Nahal Habibi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Torben Hansen": {"name": "Torben Hansen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chuiguo Huang": {"name": "Chuiguo Huang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Arianna Harris-Kawano": {"name": "Arianna Harris-Kawano", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Heba M. Ismail": {"name": "Heba M. Ismail", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Benjamin Hoag": {"name": "Benjamin Hoag", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert W. Koivula": {"name": "Robert W. Koivula", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Aaron Leong": {"name": "Aaron Leong", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gloria K. W. Leung": {"name": "Gloria K. W. Leung", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ingrid M. Libman": {"name": "Ingrid M. Libman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kai Liu": {"name": "Kai Liu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "S. Alice Long": {"name": "S. Alice Long", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "William L. Lowe": {"name": "William L. Lowe", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert W. Morton": {"name": "Robert W. Morton", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ayesha A. Motala": {"name": "Ayesha A. Motala", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Suna Onengut-Gumuscu": {"name": "Suna Onengut-Gumuscu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "James S. Pankow": {"name": "James S. Pankow", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maleesa Pathirana": {"name": "Maleesa Pathirana", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sofia Pazmino": {"name": "Sofia Pazmino", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dianna Perez": {"name": "Dianna Perez", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John R. Petrie": {"name": "John R. Petrie", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Camille E. Powe": {"name": "Camille E. Powe", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alejandra Quinteros": {"name": "Alejandra Quinteros", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rashmi Jain": {"name": "Rashmi Jain", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Debashree Ray": {"name": "Debashree Ray", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mathias Ried-Larsen": {"name": "Mathias Ried-Larsen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Zeb Saeed": {"name": "Zeb Saeed", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Vanessa Santhakumar": {"name": "Vanessa Santhakumar", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sarah Kanbour": {"name": "Sarah Kanbour", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sudipa Sarkar": {"name": "Sudipa Sarkar", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gabriela S. F. Monaco": {"name": "Gabriela S. F. Monaco", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Denise M. Scholtens": {"name": "Denise M. Scholtens", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elizabeth Selvin": {"name": "Elizabeth Selvin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wayne Huey-Herng Sheu": {"name": "Wayne Huey-Herng Sheu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Cate Speake": {"name": "Cate Speake", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nele Steenackers": {"name": "Nele Steenackers", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrea K. Steck": {"name": "Andrea K. Steck", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Norbert Stefan": {"name": "Norbert Stefan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Julie St\u00f8y": {"name": "Julie St\u00f8y", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rachael Taylor": {"name": "Rachael Taylor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sok Cin Tye": {"name": "Sok Cin Tye", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gebresilasea Gendisha Ukke": {"name": "Gebresilasea Gendisha Ukke", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marzhan Urazbayeva": {"name": "Marzhan Urazbayeva", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bart Van der Schueren": {"name": "Bart Van der Schueren", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Camille Vatier": {"name": "Camille Vatier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John M. Wentworth": {"name": "John M. Wentworth", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wesley Hannah": {"name": "Wesley Hannah", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sara L. White": {"name": "Sara L. White", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gechang Yu": {"name": "Gechang Yu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yingchai Zhang": {"name": "Yingchai Zhang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Shao J. Zhou": {"name": "Shao J. Zhou", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jacques Beltrand": {"name": "Jacques Beltrand", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michel Polak": {"name": "Michel Polak", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ingvild Aukrust": {"name": "Ingvild Aukrust", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elisa de Franco": {"name": "Elisa de Franco", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sarah E. Flanagan": {"name": "Sarah E. Flanagan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kristin A. Maloney": {"name": "Kristin A. Maloney", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew McGovern": {"name": "Andrew McGovern", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Janne Molnes": {"name": "Janne Molnes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mariam Nakabuye": {"name": "Mariam Nakabuye", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "P\u00e5l Rasmus Nj\u00f8lstad": {"name": "P\u00e5l Rasmus Nj\u00f8lstad", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hugo Pomares-Millan": {"name": "Hugo Pomares-Millan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michele Provenzano": {"name": "Michele Provenzano", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "C\u00e9cile Saint-Martin": {"name": "C\u00e9cile Saint-Martin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Cuilin Zhang": {"name": "Cuilin Zhang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yeyi Zhu": {"name": "Yeyi Zhu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sungyoung Auh": {"name": "Sungyoung Auh", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Russell de Souza": {"name": "Russell de Souza", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrea J. Fawcett": {"name": "Andrea J. Fawcett", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chandra Gruber": {"name": "Chandra Gruber", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Eskedar Getie Mekonnen": {"name": "Eskedar Getie Mekonnen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily Mixter": {"name": "Emily Mixter", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Diana Sherifali": {"name": "Diana Sherifali", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert H. Eckel": {"name": "Robert H. Eckel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John J. Nolan": {"name": "John J. Nolan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Louis H. Philipson": {"name": "Louis H. Philipson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rebecca J. Brown": {"name": "Rebecca J. Brown", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Liana K. Billings": {"name": "Liana K. Billings", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kristen Boyle": {"name": "Kristen Boyle", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tina Costacou": {"name": "Tina Costacou", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jose C. Florez": {"name": "Jose C. Florez", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anna L. Gloyn": {"name": "Anna L. Gloyn", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maria F. Gomez": {"name": "Maria F. Gomez", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Peter A. Gottlieb": {"name": "Peter A. Gottlieb", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Siri Atma W. Greeley": {"name": "Siri Atma W. Greeley", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kurt Griffin": {"name": "Kurt Griffin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew T. Hattersley": {"name": "Andrew T. Hattersley", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Irl B. Hirsch": {"name": "Irl B. Hirsch", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marie-France Hivert": {"name": "Marie-France Hivert", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Korey K. Hood": {"name": "Korey K. Hood", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jami L. Josefson": {"name": "Jami L. Josefson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Soo Heon Kwak": {"name": "Soo Heon Kwak", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lori M. Laffel": {"name": "Lori M. Laffel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Siew S. Lim": {"name": "Siew S. Lim", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ruth J. F. Loos": {"name": "Ruth J. F. Loos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ronald C. W. Ma": {"name": "Ronald C. W. Ma", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chantal Mathieu": {"name": "Chantal Mathieu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nestoras Mathioudakis": {"name": "Nestoras Mathioudakis", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "James B. Meigs": {"name": "James B. Meigs", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Shivani Misra": {"name": "Shivani Misra", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Viswanathan Mohan": {"name": "Viswanathan Mohan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rinki Murphy": {"name": "Rinki Murphy", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Richard Oram": {"name": "Richard Oram", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katharine R. Owen": {"name": "Katharine R. Owen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Susan E. Ozanne": {"name": "Susan E. Ozanne", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wei Perng": {"name": "Wei Perng", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Toni I. Pollin": {"name": "Toni I. Pollin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rodica Pop-Busui": {"name": "Rodica Pop-Busui", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Richard E. Pratley": {"name": "Richard E. Pratley", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leanne M. Redman": {"name": "Leanne M. Redman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maria J. Redondo": {"name": "Maria J. Redondo", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rebecca M. Reynolds": {"name": "Rebecca M. Reynolds", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert K. Semple": {"name": "Robert K. Semple", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jennifer L. Sherr": {"name": "Jennifer L. Sherr", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily K. Sims": {"name": "Emily K. Sims", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Arianne Sweeting": {"name": "Arianne Sweeting", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tiinamaija Tuomi": {"name": "Tiinamaija Tuomi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Miriam S. Udler": {"name": "Miriam S. Udler", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kimberly K. Vesco": {"name": "Kimberly K. Vesco", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tina Vilsb\u00f8ll": {"name": "Tina Vilsb\u00f8ll", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert Wagner": {"name": "Robert Wagner", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Paul W. Franks": {"name": "Paul W. Franks", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maryam Kavousi": {"name": "Maryam Kavousi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maxime M. Bos": {"name": "Maxime M. Bos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hanna J. Barnes": {"name": "Hanna J. Barnes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christian L. Lino Cardenas": {"name": "Christian L. Lino Cardenas", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Doris Wong": {"name": "Doris Wong", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Haojie Lu": {"name": "Haojie Lu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chani J. Hodonsky": {"name": "Chani J. Hodonsky", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lennart P. L. Landsmeer": {"name": "Lennart P. L. Landsmeer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adam W. Turner": {"name": "Adam W. Turner", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Minjung Kho": {"name": "Minjung Kho", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Natalie R. Hasbani": {"name": "Natalie R. Hasbani", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Paul S. de Vries": {"name": "Paul S. de Vries", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Donald W. Bowden": {"name": "Donald W. Bowden", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sandesh Chopade": {"name": "Sandesh Chopade", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joris Deelen": {"name": "Joris Deelen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ernest Diez Benavente": {"name": "Ernest Diez Benavente", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Edith Hofer": {"name": "Edith Hofer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Shih-Jen Hwang": {"name": "Shih-Jen Hwang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sharon M. Lutz": {"name": "Sharon M. Lutz", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leo-Pekka Lyytik\u00e4inen": {"name": "Leo-Pekka Lyytik\u00e4inen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lotte Slenders": {"name": "Lotte Slenders", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Albert V. Smith": {"name": "Albert V. Smith", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jessica van Setten": {"name": "Jessica van Setten", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Quenna Wong": {"name": "Quenna Wong", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lisa R. Yanek": {"name": "Lisa R. Yanek", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Diane M. Becker": {"name": "Diane M. Becker", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marian Beekman": {"name": "Marian Beekman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Matthew J. Budoff": {"name": "Matthew J. Budoff", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mary F. Feitosa": {"name": "Mary F. Feitosa", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chris Finan": {"name": "Chris Finan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Austin T. Hilliard": {"name": "Austin T. Hilliard", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sharon L. R. Kardia": {"name": "Sharon L. R. Kardia", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jason C. Kovacic": {"name": "Jason C. Kovacic", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brian G. Kral": {"name": "Brian G. Kral", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Carl D. Langefeld": {"name": "Carl D. Langefeld", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lenore J. Launer": {"name": "Lenore J. Launer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Shaista Malik": {"name": "Shaista Malik", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Firdaus A. A. Mohamed Hoesein": {"name": "Firdaus A. A. Mohamed Hoesein", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michal Mokry": {"name": "Michal Mokry", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Reinhold Schmidt": {"name": "Reinhold Schmidt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jennifer A. Smith": {"name": "Jennifer A. Smith", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "James G. Terry": {"name": "James G. Terry", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jeroen van der Grond": {"name": "Jeroen van der Grond", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joyce van Meurs": {"name": "Joyce van Meurs", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rozemarijn Vliegenthart": {"name": "Rozemarijn Vliegenthart", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jianzhao Xu": {"name": "Jianzhao Xu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kendra A. Young": {"name": "Kendra A. Young", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nuno R. Zilh\u00e3o": {"name": "Nuno R. Zilh\u00e3o", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert Zweiker": {"name": "Robert Zweiker", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Themistocles L. Assimes": {"name": "Themistocles L. Assimes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lewis C. Becker": {"name": "Lewis C. Becker", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniel Bos": {"name": "Daniel Bos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "J. Jeffrey Carr": {"name": "J. Jeffrey Carr", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "L. Adrienne Cupples": {"name": "L. Adrienne Cupples", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dominique P. v. de Kleijn": {"name": "Dominique P. v. de Kleijn", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Menno de Winther": {"name": "Menno de Winther", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hester M. den Ruijter": {"name": "Hester M. den Ruijter", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Barry I. Freedman": {"name": "Barry I. Freedman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Vilmundur Gudnason": {"name": "Vilmundur Gudnason", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Aroon D. Hingorani": {"name": "Aroon D. Hingorani", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John E. Hokanson": {"name": "John E. Hokanson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "M. Arfan Ikram": {"name": "M. Arfan Ikram", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ivana I\u0161gum": {"name": "Ivana I\u0161gum", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "David R. Jacobs": {"name": "David R. Jacobs", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mika K\u00e4h\u00f6nen": {"name": "Mika K\u00e4h\u00f6nen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Terho Lehtim\u00e4ki": {"name": "Terho Lehtim\u00e4ki", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gerard Pasterkamp": {"name": "Gerard Pasterkamp", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Olli T. Raitakari": {"name": "Olli T. Raitakari", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Helena Schmidt": {"name": "Helena Schmidt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "P. Eline Slagboom": {"name": "P. Eline Slagboom", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andr\u00e9 G. Uitterlinden": {"name": "Andr\u00e9 G. Uitterlinden", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Meike W. Vernooij": {"name": "Meike W. Vernooij", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joshua C. Bis": {"name": "Joshua C. Bis", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nora Franceschini": {"name": "Nora Franceschini", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bruce M. Psaty": {"name": "Bruce M. Psaty", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wendy S. Post": {"name": "Wendy S. Post", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Johan L. M. Bj\u00f6rkegren": {"name": "Johan L. M. Bj\u00f6rkegren", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christopher J. O\u2019Donnell": {"name": "Christopher J. O\u2019Donnell", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lawrence F. Bielak": {"name": "Lawrence F. Bielak", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Patricia A. Peyser": {"name": "Patricia A. Peyser", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rajeev Malhotra": {"name": "Rajeev Malhotra", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sander W. van der Laan": {"name": "Sander W. van der Laan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Clint L. Miller": {"name": "Clint L. Miller", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily B. Hill": {"name": "Emily B. Hill", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Diana Ir": {"name": "Diana Ir", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Daniel N. Frank": {"name": "Daniel N. Frank", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Purevsuren Jambal": {"name": "Purevsuren Jambal", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Danielle M. Ostendorf": {"name": "Danielle M. Ostendorf", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jared J. Scorsone": {"name": "Jared J. Scorsone", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Liza Wayland": {"name": "Liza Wayland", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kristen Bing": {"name": "Kristen Bing", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Paul S. MacLean": {"name": "Paul S. MacLean", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Edward L. Melanson": {"name": "Edward L. Melanson", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Daniel H. Bessesen": {"name": "Daniel H. Bessesen", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Victoria A. Catenacci": {"name": "Victoria A. Catenacci", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Sarah J. Borengasser": {"name": "Sarah J. Borengasser", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Andrew J. Hoisington": {"name": "Andrew J. Hoisington", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Christopher E. Stamper": {"name": "Christopher E. Stamper", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Katherine L. Bates": {"name": "Katherine L. Bates", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michael C. Flux": {"name": "Michael C. Flux", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Teodor T. Postolache": {"name": "Teodor T. Postolache", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Christopher A. Lowry": {"name": "Christopher A. Lowry", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Lisa A. Brenner": {"name": "Lisa A. Brenner", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "John D. Sterrett": {"name": "John D. Sterrett", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rosanna L. Garris": {"name": "Rosanna L. Garris", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ruth E. Quispe-Pilco": {"name": "Ruth E. Quispe-Pilco", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniel N Frank": {"name": "Daniel N Frank", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Sarah J Borengasser": {"name": "Sarah J Borengasser", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Danielle M Ostendorf": {"name": "Danielle M Ostendorf", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Janet C Siebert": {"name": "Janet C Siebert", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Daniel H Bessesen": {"name": "Daniel H Bessesen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Paul S MacLean": {"name": "Paul S MacLean", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Edward L Melanson": {"name": "Edward L Melanson", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Victoria A Catenacci": {"name": "Victoria A Catenacci", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Christopher E Stamper": {"name": "Christopher E Stamper", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kelly A Stearns-Yoder": {"name": "Kelly A Stearns-Yoder", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Andrew J Hoisington": {"name": "Andrew J Hoisington", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Diana P Brostow": {"name": "Diana P Brostow", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jeri E Forster": {"name": "Jeri E Forster", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Teodor T Postolache": {"name": "Teodor T Postolache", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Christopher A Lowry": {"name": "Christopher A Lowry", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Lisa A Brenner": {"name": "Lisa A Brenner", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Elizabeth Litkowski": {"name": "Elizabeth Litkowski", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kylie K Harrall": {"name": "Kylie K Harrall", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jessica Shaw": {"name": "Jessica Shaw", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Deborah H Glueck": {"name": "Deborah H Glueck", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Catherine C Cohen": {"name": "Catherine C Cohen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katherine A Sauder": {"name": "Katherine A Sauder", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brandy M Ringham": {"name": "Brandy M Ringham", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anna Bellatorre": {"name": "Anna Bellatorre", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ann Scherzinger": {"name": "Ann Scherzinger", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kartik Shankar": {"name": "Kartik Shankar", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ruby Fore": {"name": "Ruby Fore", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sheryl L Rifas-Shiman": {"name": "Sheryl L Rifas-Shiman", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Emily Oken": {"name": "Emily Oken", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Neil A Zakai": {"name": "Neil A Zakai", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mariah Meyer": {"name": "Mariah Meyer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mindy D Szeto": {"name": "Mindy D Szeto", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Colton Leavitt": {"name": "Colton Leavitt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jonathan A Shortt": {"name": "Jonathan A Shortt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Timothy A Thornton": {"name": "Timothy A Thornton", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Russell P Tracy": {"name": "Russell P Tracy", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Paul L Auer": {"name": "Paul L Auer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nels C Olson": {"name": "Nels C Olson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adnin Zaman": {"name": "Adnin Zaman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Iain R Konigsberg": {"name": "Iain R Konigsberg", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jared J Scorsone": {"name": "Jared J Scorsone", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Catherine A Lozupone": {"name": "Catherine A Lozupone", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Carsten G\u00f6rg": {"name": "Carsten G\u00f6rg", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniel Bessesen": {"name": "Daniel Bessesen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Diana P. Brostow": {"name": "Diana P. Brostow", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kelly A. Stearns-Yoder": {"name": "Kelly A. Stearns-Yoder", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alexandra Schneider": {"name": "Alexandra Schneider", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jeri E. Forster": {"name": "Jeri E. Forster", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maggie A Stanislawksi": {"name": "Maggie A Stanislawksi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Claire A Hoffmire": {"name": "Claire A Hoffmire", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Alexandra L Schneider": {"name": "Alexandra L Schneider", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mireia Gascon": {"name": "Mireia Gascon", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alyssa W Beavers": {"name": "Alyssa W Beavers", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Katherine Alaimo": {"name": "Katherine Alaimo", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Angel Villalobos": {"name": "Angel Villalobos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "James R Hebert": {"name": "James R Hebert", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kelsey Dexter": {"name": "Kelsey Dexter", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kaigang Li": {"name": "Kaigang Li", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jill Litt": {"name": "Jill Litt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joseph Walker Keach": {"name": "Joseph Walker Keach", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anna E Bar\u00f3n": {"name": "Anna E Bar\u00f3n", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Mary E Plomondon": {"name": "Mary E Plomondon", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Paula Langner": {"name": "Paula Langner", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Amit Amin": {"name": "Amit Amin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Heather M Gilmartin": {"name": "Heather M Gilmartin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephen Waldo": {"name": "Stephen Waldo", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Thomas M Maddox": {"name": "Thomas M Maddox", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Archana Asundi": {"name": "Archana Asundi", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Payal Mehta": {"name": "Payal Mehta", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Hillary J Mull": {"name": "Hillary J Mull", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Marin L Schweizer": {"name": "Marin L Schweizer", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "P Michael Ho": {"name": "P Michael Ho", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kalpana Gupta": {"name": "Kalpana Gupta", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Westyn Branch-Elliman": {"name": "Westyn Branch-Elliman", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Kelly Stolzmann": {"name": "Kelly Stolzmann", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emily Kalver": {"name": "Emily Kalver", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marlena H Shin": {"name": "Marlena H Shin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brandie D Wagner": {"name": "Brandie D Wagner", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Anna E Baron": {"name": "Anna E Baron", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Peter J Zimetbaum": {"name": "Peter J Zimetbaum", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brandie D. Wagner": {"name": "Brandie D. Wagner", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Nina Iszatt": {"name": "Nina Iszatt", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Cecilie Dahl": {"name": "Cecilie Dahl", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Marci K. Sontag": {"name": "Marci K. Sontag", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Rob Knight": {"name": "Rob Knight", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Catherine A. Lozupone": {"name": "Catherine A. Lozupone", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Merete Eggesb\u00f8": {"name": "Merete Eggesb\u00f8", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Omar Jawaid": {"name": "Omar Jawaid", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rory Bricker": {"name": "Rory Bricker", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gary K Grunwald": {"name": "Gary K Grunwald", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Javier A Valle": {"name": "Javier A Valle", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ehrin J Armstrong": {"name": "Ehrin J Armstrong", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephen W Waldo": {"name": "Stephen W Waldo", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jared D Heinze": {"name": "Jared D Heinze", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniel A Hadidi": {"name": "Daniel A Hadidi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Susana Santos": {"name": "Susana Santos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Iris Eekhout": {"name": "Iris Eekhout", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ellis Voerman": {"name": "Ellis Voerman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Henrique Barros": {"name": "Henrique Barros", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marie-Aline Charles": {"name": "Marie-Aline Charles", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leda Chatzi": {"name": "Leda Chatzi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "C\u00e9cile Chevrier": {"name": "C\u00e9cile Chevrier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "George P Chrousos": {"name": "George P Chrousos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Eva Corpeleijn": {"name": "Eva Corpeleijn", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nathalie Costet": {"name": "Nathalie Costet", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sarah Crozier": {"name": "Sarah Crozier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Myriam Doyon": {"name": "Myriam Doyon", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maria Pia Fantini": {"name": "Maria Pia Fantini", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sara Farchi": {"name": "Sara Farchi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Francesco Forastiere": {"name": "Francesco Forastiere", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Luigi Gagliardi": {"name": "Luigi Gagliardi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Vagelis Georgiu": {"name": "Vagelis Georgiu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Keith M Godfrey": {"name": "Keith M Godfrey", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Davide Gori": {"name": "Davide Gori", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Veit Grote": {"name": "Veit Grote", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wojciech Hanke": {"name": "Wojciech Hanke", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Irva Hertz-Picciotto": {"name": "Irva Hertz-Picciotto", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Barbara Heude": {"name": "Barbara Heude", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniel Hryhorczuk": {"name": "Daniel Hryhorczuk", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rae-Chi Huang": {"name": "Rae-Chi Huang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hazel Inskip": {"name": "Hazel Inskip", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Todd A Jusko": {"name": "Todd A Jusko", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anne M Karvonen": {"name": "Anne M Karvonen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Berthold Koletzko": {"name": "Berthold Koletzko", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leanne K K\u00fcpers": {"name": "Leanne K K\u00fcpers", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hanna Lagstr\u00f6m": {"name": "Hanna Lagstr\u00f6m", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Debbie A Lawlor": {"name": "Debbie A Lawlor", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Irina Lehmann": {"name": "Irina Lehmann", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maria-Jose Lopez-Espinosa": {"name": "Maria-Jose Lopez-Espinosa", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Per Magnus": {"name": "Per Magnus", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Renata Majewska": {"name": "Renata Majewska", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Johanna M\u00e4kel\u00e4": {"name": "Johanna M\u00e4kel\u00e4", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yannis Manios": {"name": "Yannis Manios", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sheila W McDonald": {"name": "Sheila W McDonald", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Monique Mommers": {"name": "Monique Mommers", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Camilla S Morgen": {"name": "Camilla S Morgen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "George Moschonis": {"name": "George Moschonis", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "\u013dubica Mur\u00ednov\u00e1": {"name": "\u013dubica Mur\u00ednov\u00e1", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John Newnham": {"name": "John Newnham", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ellen A Nohr": {"name": "Ellen A Nohr", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Anne-Marie Nybo Andersen": {"name": "Anne-Marie Nybo Andersen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adri\u00ebtte J J M Oostvogels": {"name": "Adri\u00ebtte J J M Oostvogels", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Agnieszka Pac": {"name": "Agnieszka Pac", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Eleni Papadopoulou": {"name": "Eleni Papadopoulou", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Juha Pekkanen": {"name": "Juha Pekkanen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Costanza Pizzi": {"name": "Costanza Pizzi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kinga Polanska": {"name": "Kinga Polanska", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniela Porta": {"name": "Daniela Porta", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lorenzo Richiardi": {"name": "Lorenzo Richiardi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nel Roeleveld": {"name": "Nel Roeleveld", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Loreto Santa-Marina": {"name": "Loreto Santa-Marina", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ana C Santos": {"name": "Ana C Santos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Henriette A Smit": {"name": "Henriette A Smit", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Thorkild I A S\u00f8rensen": {"name": "Thorkild I A S\u00f8rensen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marie Standl": {"name": "Marie Standl", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Camilla Stoltenberg": {"name": "Camilla Stoltenberg", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elisabeth Thiering": {"name": "Elisabeth Thiering", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Carel Thijs": {"name": "Carel Thijs", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maties Torrent": {"name": "Maties Torrent", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Suzanne C Tough": {"name": "Suzanne C Tough", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tomas Trnovec": {"name": "Tomas Trnovec", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marleen M H J van Gelder": {"name": "Marleen M H J van Gelder", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lenie van Rossem": {"name": "Lenie van Rossem", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrea von Berg": {"name": "Andrea von Berg", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Martine Vrijheid": {"name": "Martine Vrijheid", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tanja G M Vrijkotte": {"name": "Tanja G M Vrijkotte", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Oleksandr Zvinchuk": {"name": "Oleksandr Zvinchuk", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stef van Buuren": {"name": "Stef van Buuren", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Vincent W V Jaddoe": {"name": "Vincent W V Jaddoe", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Marci K Sontag": {"name": "Marci K Sontag", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ehrin J. Armstrong": {"name": "Ehrin J. Armstrong", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Damianos G. Kokkinidis": {"name": "Damianos G. Kokkinidis", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mary E. Plomondon": {"name": "Mary E. Plomondon", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Anna E. Bar\u00f3n": {"name": "Anna E. Bar\u00f3n", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Jay Giri": {"name": "Jay Giri", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kendrick A. Shunk": {"name": "Kendrick A. Shunk", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Subhash Banerjee": {"name": "Subhash Banerjee", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Thomas M. Maddox": {"name": "Thomas M. Maddox", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Stephen W. Waldo": {"name": "Stephen W. Waldo", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Howard Gold": {"name": "Howard Gold", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hillary Mull": {"name": "Hillary Mull", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "P. Michael Ho": {"name": "P. Michael Ho", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Ateka Gunja": {"name": "Ateka Gunja", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Steven M. Bradley": {"name": "Steven M. Bradley", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Mladen I. Vidovich": {"name": "Mladen I. Vidovich", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Amit N. Vora": {"name": "Amit N. Vora", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gary K. Grunwald": {"name": "Gary K. Grunwald", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "John S. Rumsfeld": {"name": "John S. Rumsfeld", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Walter Woody": {"name": "Walter Woody", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brahmajee K. Nallamothu": {"name": "Brahmajee K. Nallamothu", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Hitinder S. Gurm": {"name": "Hitinder S. Gurm", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sunil V. Rao": {"name": "Sunil V. Rao", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Thomas T. Tsai": {"name": "Thomas T. Tsai", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Alan H. Schob": {"name": "Alan H. Schob", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Javier A. Valle": {"name": "Javier A. Valle", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Carlos E. Alfonso": {"name": "Carlos E. Alfonso", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Emmanouil S. Brilakis": {"name": "Emmanouil S. Brilakis", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Siddhartha Mandal": {"name": "Siddhartha Mandal", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jose C. Clemente": {"name": "Jose C. Clemente", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hein Stigum": {"name": "Hein Stigum", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Melissa M. Farmer": {"name": "Melissa M. Farmer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bevanne Bean-Mayberry": {"name": "Bevanne Bean-Mayberry", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nataria T. Joseph": {"name": "Nataria T. Joseph", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lauren E. Thompson": {"name": "Lauren E. Thompson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jessica L. Zuchowski": {"name": "Jessica L. Zuchowski", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stacie L. Daugherty": {"name": "Stacie L. Daugherty", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elizabeth M. Yano": {"name": "Elizabeth M. Yano", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sian M.J. Hemmings": {"name": "Sian M.J. Hemmings", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stefanie Malan-M\u00fcller": {"name": "Stefanie Malan-M\u00fcller", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leigh L. van den Heuvel": {"name": "Leigh L. van den Heuvel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brittany A. Demmitt": {"name": "Brittany A. Demmitt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "David G. Smith": {"name": "David G. Smith", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adam D. Bohr": {"name": "Adam D. Bohr", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Embriette R. Hyde": {"name": "Embriette R. Hyde", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "James T. Morton": {"name": "James T. Morton", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Clarisse A. Marotz": {"name": "Clarisse A. Marotz", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Philip H. Siebler": {"name": "Philip H. Siebler", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maarten Braspenning": {"name": "Maarten Braspenning", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wim Van Criekinge": {"name": "Wim Van Criekinge", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Matthew B. McQueen": {"name": "Matthew B. McQueen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kenneth S. Krauter": {"name": "Kenneth S. Krauter", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Soraya Seedat": {"name": "Soraya Seedat", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Amneet Sandhu": {"name": "Amneet Sandhu", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Kathryn Guinn": {"name": "Kathryn Guinn", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Javier Valle": {"name": "Javier Valle", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Daniel Matlock": {"name": "Daniel Matlock", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bradley A. Maron": {"name": "Bradley A. Maron", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Edward Hess": {"name": "Edward Hess", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alexander R. Opotowsky": {"name": "Alexander R. Opotowsky", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ryan J. Tedford": {"name": "Ryan J. Tedford", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tim Lahm": {"name": "Tim Lahm", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Karen E. Joynt": {"name": "Karen E. Joynt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Daniel J. Kass": {"name": "Daniel J. Kass", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Thomas Stephens": {"name": "Thomas Stephens", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Erik R. Swenson": {"name": "Erik R. Swenson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ronald H. Goldstein": {"name": "Ronald H. Goldstein", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jane A. Leopold": {"name": "Jane A. Leopold", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Roham T. Zamanian": {"name": "Roham T. Zamanian", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jean M. Elwing": {"name": "Jean M. Elwing", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gaurav Choudhary": {"name": "Gaurav Choudhary", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Judith Strymish": {"name": "Judith Strymish", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Paul D. Varosy": {"name": "Paul D. Varosy", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Howard S. Gold": {"name": "Howard S. Gold", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Geoffrey D. Barnes": {"name": "Geoffrey D. Barnes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Wenhui Liu": {"name": "Wenhui Liu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew Klein": {"name": "Andrew Klein", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "David B. Bekelman": {"name": "David B. Bekelman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Lindsey L. Monteith": {"name": "Lindsey L. Monteith", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Beth E. Cohen": {"name": "Beth E. Cohen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John H. Schilling": {"name": "John H. Schilling", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Stephen C. Hunt": {"name": "Stephen C. Hunt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Debra Milek": {"name": "Debra Milek", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Supriya Shore": {"name": "Supriya Shore", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Monica M. Matthieu": {"name": "Monica M. Matthieu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Manesh R. Patel": {"name": "Manesh R. Patel", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "David J. Magid": {"name": "David J. Magid", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Benjamin Leon": {"name": "Benjamin Leon", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Deepak L. Bhatt": {"name": "Deepak L. Bhatt", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Stephan D. Fihn": {"name": "Stephan D. Fihn", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Colin I. O\u2019Donnell": {"name": "Colin I. O\u2019Donnell", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Eric D. Peterson": {"name": "Eric D. Peterson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Colin O\u2019Donnell": {"name": "Colin O\u2019Donnell", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Adhir R. Shroff": {"name": "Adhir R. Shroff", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bernadette Speiser": {"name": "Bernadette Speiser", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert J. Jesse": {"name": "Robert J. Jesse", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Vikas Aggarwal": {"name": "Vikas Aggarwal", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Gary Grunwald": {"name": "Gary Grunwald", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jill C. Adams": {"name": "Jill C. Adams", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ivan P. Casserly": {"name": "Ivan P. Casserly", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Antonio Gutierrez": {"name": "Antonio Gutierrez", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mladen Vidovich": {"name": "Mladen Vidovich", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christopher L. Bryson": {"name": "Christopher L. Bryson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "John Rumsfeld": {"name": "John Rumsfeld", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jade Young": {"name": "Jade Young", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jun Inamo": {"name": "Jun Inamo", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Revanth Krishna": {"name": "Revanth Krishna", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Fan Zhang": {"name": "Fan Zhang", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Rachel V. Horejsi": {"name": "Rachel V. Horejsi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Carly Weber": {"name": "Carly Weber", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Blake Mathisen": {"name": "Blake Mathisen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Chase N. Nelson": {"name": "Chase N. Nelson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Maggie Bagatta": {"name": "Maggie Bagatta", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ireland Coughlin": {"name": "Ireland Coughlin", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Megan Wettstein": {"name": "Megan Wettstein", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ankit Kulshrestha": {"name": "Ankit Kulshrestha", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Hui Siang Benjamin Lee": {"name": "Hui Siang Benjamin Lee", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leonardo R. Nunn": {"name": "Leonardo R. Nunn", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mostafa Zamanian": {"name": "Mostafa Zamanian", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nicolas J. Wheeler": {"name": "Nicolas J. Wheeler", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Jordan Langlois": {"name": "Jordan Langlois", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Connor McKeown": {"name": "Connor McKeown", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mikayla Hady": {"name": "Mikayla Hady", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Samuel Stumo": {"name": "Samuel Stumo", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Suman Setty": {"name": "Suman Setty", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michael Walsh": {"name": "Michael Walsh", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Rahul Gomes": {"name": "Rahul Gomes", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Felicia Ebot-Ojong": {"name": "Felicia Ebot-Ojong", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Aileen R. Ferraro": {"name": "Aileen R. Ferraro", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Rochelle E. Yap": {"name": "Rochelle E. Yap", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Farh Kaddar": {"name": "Farh Kaddar", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Clayton Hull-Crew": {"name": "Clayton Hull-Crew", "kind": "collaborator", "size": 0.8, "color": "#999999"}, "Abigail M. Deaven": {"name": "Abigail M. Deaven", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew D. Klocko": {"name": "Andrew D. Klocko", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Zachary A. Lewis": {"name": "Zachary A. Lewis", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Victoria L. Buchanan": {"name": "Victoria L. Buchanan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kendra R. Ferrier": {"name": "Kendra R. Ferrier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brian D. Chen": {"name": "Brian D. Chen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Robert E. Gerzsten": {"name": "Robert E. Gerzsten", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ruth J.F. Loos": {"name": "Ruth J.F. Loos", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Josyf C. Mychaleckyj": {"name": "Josyf C. Mychaleckyj", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Opeyemi A. Olabisi": {"name": "Opeyemi A. Olabisi", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alex P. Reiner": {"name": "Alex P. Reiner", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Amy K. Mottl": {"name": "Amy K. Mottl", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Burcu F. Darst": {"name": "Burcu F. Darst", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christopher A. Haiman": {"name": "Christopher A. Haiman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Alayne S. Graybill": {"name": "Alayne S. Graybill", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Tiffany J. Lundberg": {"name": "Tiffany J. Lundberg", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Nickolas M. Lande": {"name": "Nickolas M. Lande", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Sara Rodriguez": {"name": "Sara Rodriguez", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew T Reckard": {"name": "Andrew T Reckard", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Yulia Shtanko": {"name": "Yulia Shtanko", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew D Klocko": {"name": "Andrew D Klocko", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Nathan D. Young": {"name": "Nathan D. Young", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joseph C. Cleveland": {"name": "Joseph C. Cleveland", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tamara D. Simon": {"name": "Tamara D. Simon", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Douglas L. Vanderbilt": {"name": "Douglas L. Vanderbilt", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Juan Espinoza": {"name": "Juan Espinoza", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Christine B. Mirzaian": {"name": "Christine B. Mirzaian", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Tanya L. Alderete": {"name": "Tanya L. Alderete", "kind": "collaborator", "size": 0.5, "color": "#999999"}, "Jing Qian": {"name": "Jing Qian", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Matthew R. Olm": {"name": "Matthew R. Olm", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Ying Zhu": {"name": "Ying Zhu", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Kelsey M Smith": {"name": "Kelsey M Smith", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew S Greenberg": {"name": "Andrew S Greenberg", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Sheldon Rowan": {"name": "Sheldon Rowan", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bridget Chalifour": {"name": "Bridget Chalifour", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Elizabeth A. Holzhausen": {"name": "Elizabeth A. Holzhausen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joseph J. Lim": {"name": "Joseph J. Lim", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Natalie Shen": {"name": "Natalie Shen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Dean P. Jones": {"name": "Dean P. Jones", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Bradley S. Peterson": {"name": "Bradley S. Peterson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Michael I. Goran": {"name": "Michael I. Goran", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Donghai Liang": {"name": "Donghai Liang", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "M\u00fcge Sak": {"name": "M\u00fcge Sak", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Brian J. Williams": {"name": "Brian J. Williams", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Cory T. Zumbar": {"name": "Cory T. Zumbar", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Landon Teer": {"name": "Landon Teer", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Mustafa N. G. Al-Kawaaz": {"name": "Mustafa N. G. Al-Kawaaz", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Andrew J. Hey": {"name": "Andrew J. Hey", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Megan J. Wilson": {"name": "Megan J. Wilson", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Leslie M. Schier": {"name": "Leslie M. Schier", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Joseph Chen": {"name": "Joseph Chen", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Norman L. Lehman": {"name": "Norman L. Lehman", "kind": "collaborator", "size": 0.3, "color": "#999999"}, "Janet C. Siebert": {"name": "Janet C. Siebert", "kind": "collaborator", "size": 0.3, "color": "#999999"}}, "metadata": null}]}}, "title": "webweb"}